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Abstract 
 
 
 
Excitotoxicity is the major contributor to the pathophysiological damage after acute 
spinal cord injury which is often incomplete, yet it produces paralysis with uncertain 
outcome for gait recovery despite early intensive care support. Neuroprotecting the 
spinal cord during the early phase of injury is an important goal to determine a 
favourable outcome to suppress delayed pathological events that extend the primary 
damage and amplify the loss of motor function often with irreversible consequences. 
While intensive care and neurosurgical intervention remain mainstay treatments, 
effective neuroprotection requires further focused experimental studies under 
controlled conditions.  
To better understand the pathophysiological mechanism of spinal lesion an in vitro 
model of rat spinal cord has been developed by our laboratory whereby injury is 
mimicked by a moderate excitotoxic insult. Such an injury suppresses the locomotor 
networks together with partial loss of motoneuronal population. The present thesis 
explores if the volatile general anesthetic methoxyflurane can protect spinal 
locomotor networks from kainate induced excitotoxicity and whether motoneuronal 
survival after excitotoxicity relies on cell expression of heat shock protein 70 
(HSP70), a cytosolic neuroprotective protein binding and sequestering metabolic 
distress-generated proteins.  
The protocols involved 1 h excitotoxic stimulation on day 1 followed by 
electrophysiological and immunohistochemical testing after 24 h. A time-limited (1 
h), single administration of methoxyfluorane together with kainate (or with 30 min or 
60 min delay), prevented any depression of spinal reflexes, loss of motoneuron 
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excitability, and histological damage. Methoxyfluorane per se temporarily decreased 
synaptic transmission and motoneuron excitability. These effects were readily 
reversible on washout. When methoxyfluorane was applied with or after kainate, 
spinal locomotor activity recorded as alternating electrical discharges from lumbar 
motor pools was fully preserved after 24 h. Furthermore to test the second hypothesis, 
the motoneurons were investigated for their expression of apoptosis inducing factor 
(AIF; a known biomarker of cell death) which became preferentially localized to the 
nucleus in pyknotic cells after excitotoxicity. The surviving motoneurons showed 
strong expression of HSP70 with no nuclear AIF. The sham preparations did not 
show any AIF nuclear translocation whereas the preparations treated with kainate 
(100 µM) were the most affected. VER155008, a pharmacological inhibitor of 
HSP70, per se induced neurotoxicity comparable to that of kainate. 
Electrophysiological recording indicated depression of motoneuron field potential 
with strong decrease in excitability and impaired synaptic transmission following 
kainate or VER155008. Their combined application elicited more intense 
neurotoxicity. Interestingly, motoneurons in the spinal cord (24 h in vitro) showed 
large expression of HSP70 compared to freshly dissected tissue, suggesting that 
HSP70 up-regulation was critical for spinal cord preparation survival in vitro. 
These data suggest that a volatile general anesthetic could provide strong 
electrophysiological and histological neuroprotection that enabled retention of 
locomotor network activity even one day after the excitotoxic challenge. Our study 
also showed that HSP70 is important for motoneuronal survival. It is hypothesized 
that the benefits of early neurosurgery for acute SCI might be enhanced if, in addition 
to injury decompression and stabilization, the protective role of general anesthesia is 
maximized. Another potential future strategy to neuroprotect motoneurons could be 
the upregulation of HSP70 activity by either using its pharmacological enhancers or 
by inducing its over-expression.  
Introduction 
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Introduction 
 
 
 
 
1. Spinal Cord 
 
The spinal cord is part of central nervous system and extends caudally. It is protected 
by vertebral bones. All the motor and sensory communication (except that of cranial 
nerves) between brain and the body travels through nerve fibers present in white 
matter tract of spinal cord. The processing of ascending and descending stimulus is 
processed by grey matter of spinal cord and is also involved in automated motor 
patterns such as walking. 
 
The role of spinal cord has been realized and expressed by the Persian physician and 
philosopher Avicenna (AD 980 - 1037) for at least a millennium ago: 
“If all the nerves exited directly from the brain, the brain would be bigger. 
For example, nerves innervating the hands and feet would travel a longer 
distance and, thus, would be more prone to injury; they would also 
become less able to innervate the big muscles of the thigh and the calf. 
Therefore, God created the spinal cord below the brain. The spinal cord is 
like a channel coming out of a fountain in the way that nerves emerge 
from both sides and go down, thus putting the organs closer to the brain. 
That is why God placed the spinal cord into a hard bony channel called the 
spine to protect it from injury.” 
(Naderi et al., 2003) 
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2. Spinal cord injury  
 
Spinal cord injury (SCI) disrupts normal motor, sensory and autonomic functions. 
Although the majority of new cases of spinal cord injury (SCI) are associated with an 
incomplete lesion, severe locomotor deficit usually ensues with resultant paralysis 
and uncertain recovery (van den Berg et al., 2010; McDonald and Sadowsky, 2002; 
Nair et al., 2005). The other symptoms of SCI include loss of sensation (heat, cold 
and touch), loss of bowel and bladder control, hypereflexia or spasms, pain, 
respiratory difficulties and changes in sexual behavior. When the level of injury is 
above the first thoracic vertebra, it is referred to as tetraplegia or quadriplegia and 
such injury affects arms, hands, trunk, legs and pelvic organs. Paraplegia injury 
(injury occurring below first thoracic nerve) affects all or parts of trunk, pelvic organs 
and legs.  
 
2.1. Epidemiology 
 
Annual incidence of acute traumatic SCI is 15 – 40/million worldwide (Rowland et 
al., 2008; Sekhon and Fehlings, 2001). SCI is associated with severe physical, 
psychological, social and economic impact on patients and their families. The 
estimated lifetime cost of a young SCI patient (25 year old), with high cervical 
tetraplegia, is approximately US $3 million (Priebe et al., 2007). The major 
contributor to SCI are vehicular accidents with 50 % of cases followed by falls and 
work related accidents (30%) (Rowland et al., 2008; Singh et al., 2014).  
In addition to traumatic SCIs, the non-traumatic SCIs are on rise and are as important 
(van den Berg et al., 2010). Non-traumatic SCIs account for 30 – 50% of spinal cord 
disorders (Nair et al., 2005) and are usually incomplete (van den Berg et al., 2010; 
McKinley et al., 1999). The major causes of non-traumatic SCI are vertebral stenosis 
(54%; McKinley et al., 1999), spinal tumors (26%; Nair et al., 2005) and other 
diseases (vascular, infective, genetic, inflammatory, metabolic and degenerative).    
Introduction 
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2.2. Classification 
 
As early as 2500 BC, Imhoteo (Egyptian physician) classified spinal cord injury as – 
“an ailment not to be treated” in Edwin Smith surgical papyrus (Hughes, 1988). But 
despite being a serious and hopeless injury in the past, the quest to find a cure to SCI 
has not been dampened, resulting in its proper classification. As of today, clinicians 
refer SCI as complete or incomplete. The first scale to grade the neurological loss was 
devised at the Stokes Manville hospital before World War II and was widely 
circulated by Frankel in 1970’s. The American Spinal Injury Association (ASIA) 
impairment scale follows Frankel scale with some important improvements and is 
clearer.  
American Spinal Injury Association (ASIA) impairment scale 
A = Complete: No motor or sensory function is preserved in the sacral segments S4-
S5. 
B = Incomplete: Sensory but not motor function is preserved below the neurological 
level and includes the sacral segments S4-S5. 
C = Incomplete: Motor function is preserved below the neurological level, and more 
than half of the key muscles below the neurological level have a muscle grade less 
than 3. 
D = Incomplete: Motor function is preserved below the neurological level, and at 
least half of key muscles below the neurological level have a muscle grade of 3 or 
more. 
E = Normal: Motor and sensory function are normal. 
  
2.3. Pathophysiology 
 
The understanding of pathophysiological processes that accompany SCI is essential 
for the development of neuroprotective strategies. The typical consequences of spinal 
cord injury in human are severe below injury, due to axonal disruption or 
demyelination. The schematic representation in Figure 1 shows damage to the 
Introduction 
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corticospinal tract (major descending pathway from the brain to the spinal cord) by 
injury that deprives motoneurons and interneurons of inputs (Thomas et al., 2014). 
This alters the excitation and inhibition balance of signals to motoneurons which 
results in recruitment of fewer motoneurons. Some motor units get weak, while some 
are paralysed and motoneuron death will initiate with denervation. The motor unit 
properties differ with different type of muscles like those for hand or limb (Thomas et 
al., 2014). Muscle function also depends upon the site of injury, namely how close or 
far away from the lesion motor pools are.  
 
 
 
 
Figure 1. Schematic of typical spinal cord injury consequences in human. 
The descending inputs from corticospinal tracts cross the midline (solid 
arrow) to reach spinal neurons but some descend via ipsilateral pathways 
(dashed arrow) (Thomas et al., 2014). 
Introduction 
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All these changes in the spinal cord after injury are part of a major process that can be 
better described in two major phases, namely primary and secondary. The primary 
injury results in traumatic severing of axons, hemorrhage, early necrosis, and 
activation of microglia. Primary injury is accompanied with “spinal shock” which can 
be defined as loss of sensation and motor paralysis, although reflexes gradually 
recover later (Hiersemenzel et al., 2000). The extension of primary lesion over the 
first few hours and days to surrounding spinal areas represents the secondary injury 
phase (Park et al., 2004; Rowland et al., 2008; Sekhon and Fehlings, 2001). It 
involves vascular dysfunction, edema, ischemia/hypoxia, excitotoxicity, free radical 
production, inflammation and delayed cell death (Dumont et al., 2001; Hall and 
Springer, 2004; Kuzhandaivel et al., 2011). These processes are explained in detail 
below.  
 
2.3.1. Primary Injury  
 
The injury resulting from a displacement of the vertebral column is known as 
compressive-contusive injury and is the most commonly observed among acute SCIs. 
It can last up to 2 h and exerts force directly on spinal cord causing disruption of 
axons, damage to blood vessels and cell membranes. The primary lesions rarely 
transect or fully disrupt the anatomical continuity of spinal cord. The damage to 
central grey matter is mostly due to the initial necrosis because of the cell membrane 
disruption and ischemia. The up-regulation of pro-inflammatory cytokines, like 
TNFα, IL-6 and IL-1β, activates the microglia (Pineau and Lacroix, 2007). The 
number of spared axons, coursing through the lesion site, is of high therapeutic 
importance (Rowland et al., 2008). Even as little as 5% of surviving axons is useful to 
preserve some neurological function in animal models (Fehlings and Tator, 1995; 
Kakulas, 2004). The concentration of extracellular glutamate can also reach 
excitotoxic levels within minutes after injury (Wrathall et al., 1996) as a result of cell 
lysis from mechanical impact and synaptic/non-synaptic release to the epicenter of 
injury.  
Introduction 
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Figure 2. Time course of spinal cord injury impact. Excitotoxicity starts 
within minutes after injury and peaks in hours to damage neurons 
followed by ischemia and inflammation. These events contribute to 
secondary phase of injury which ultimately leads to cell death (modified 
from Dirnagl et al., 1999). 
 
2.3.2. Secondary Injury 
 
The secondary injury begins minutes after primary injury and can last from several 
months to years (Park et al., 2004). 
  
Acute phase (2 h – 2 weeks) begins shortly after the time of injury. The microvascular 
damage results in ischemia causing hypoxia and metabolic dysfunction at the 
epicenter of injury and adjacent areas (Rowland et al., 2008). This deprivation leads 
to cell death through mitochondrial dysfunction as neurons are highly sensitive to 
oxygen and nutritional deficit (Kuzhandaivel et al., 2011). The release of excitatory 
neurotransmitters, glutamate and aspartate, causes cytotoxicity  (Park et al., 2004) 
because the rise in glutamate results in hyperactivation of glutamate receptors which 
might lead to neuronal cell death (Lipton and Rosenberg, 1994). The hyperactivity of 
Introduction 
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glutamate causes Na+ influx resulting in edema (Choi, 1987; Hall and Springer, 2004) 
and triggers cell death cascades (Kuzhandaivel et al., 2011). See Figure 3.  
 
Subcute phase may last from 1 to 2 months post injury. The invasion of inflammatory 
cells due to breakdown of the blood brain barrier also contributes to secondary 
damage (Popovich et al., 1997). The inflammatory response includes invasion of 
neutrophiles and cytokines. These cytokines mediate the generation of free radicals 
which will also lead to cell death. This inflammatory response is also thought to be 
neuroprotective as it promotes tissue sparing and functional recovery (Hohlfeld et al., 
2007; Rapalino et al., 1998).  
 
Chronic Stage (> 6 months) is a virtually life-long phase for spinal cord injury 
patients. The glial scar is formed following spinal cord injury by activation of 
astrocytes around the lesion together with invading meningeal fibroblasts, microglia, 
vascular endothelial cells and oligodendrocyte precursor cells (Chung et al., 2014; 
Fawcett and Asher, 1999). This glial scar can turn into cysts (with contribution to 
local ischemia, inflammation, and hemorrhage; Josephson et al., 2001; Williams et 
al., 1981) and keeps expanding from days to weeks after injury, thus making injury 
worse. The loss of oligodendrocytes leads to demyelination of spared axons and 
contributes to injury progression. 
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Figure 3. Pathophysiology of secondary spinal cord injury (Hall and 
Springer, 2004). 5-LO = 5-lipoxygenase; TXA2 = thromboxane A2; PGF2α 
= prostaglandin F2α; LTs = leukotrienes; ONOO- = peroxynitrite anion; 
PMN = polymorphonuclear leukocyte. 
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2.3.3. Excitotoxicity  
 
The major excitatory neurotransmitter in central nervous system is glutamate. It acts 
through metabotropic and ionotropic receptors. Hence, excitotoxicity refers to a 
neurotoxic state caused by hyperactivation and prolonged exposure to glutamate 
resulting in neuronal cell death (Park et al., 2004). It has been shown that the 
concentration of glutamate by induced experimental spinal injury reaches neurotoxic 
levels when administered to an uninjured spinal cord (Li et al., 1995). The excessive 
activation of glutamate receptors like NMDA, AMPA and kainate leads to influx of 
Na+ and Ca2+. This influx triggers a chain of biochemical processes like uncoupling 
of mitochondrial electron transfer from ATP synthase, activation and hyperactivity of 
calpains, Ca2+ dependant proteases, protein kinases, phospholipases and nucleases 
(Szydlowska and Tymianski, 2010; Wang et al., 2005). These events result in 
mitochondrial dysfunction and eventually cell death. AMPA and kainate receptors are 
also permeable to Ca2+ and are heteromers consisting of combination of 4 subunits, 
GluR1-4. The permeability of Ca2+ through these channels is controlled by GluR2 
subunit. The expression of GluR2 actually reduces Ca2+ permeability (Bleakman and 
Lodge, 1998). The decrease in this subunit’s expression is directly related to 
enhanced permeability of Ca2+ through AMPA receptors, making neurons highly 
vulnerable to kainate induced excitotoxicity (Friedman, 1998; Pellegrini-Giampietro 
et al., 1997). Furthermore, reduction in desensitization of AMPA receptors due to 
high glutamate concentrations causes functional abnormalities (Li and Stys, 
2000).The GluR2 subunits are absent from AMPA receptors on oligodendrocyte, 
making them more permeable to Ca2+: the importance of AMPA receptors for 
oligodendrocytes is demonstrated by the strong white matter lesion in certain spinal 
cord injury models (Agrawal and Fehlings, 1997; Li and Stys, 2000). Application of 
non-NMDA glutamate receptor antagonists helps recovery from white matter spinal 
cord injury. Conversely, NMDA antagonists are ineffective, indicating different 
mechanisms of glutamate mediated damage between white and grey matter (Agrawal 
and Fehlings, 1997; Li and Stys, 2000; Park et al., 2004). Excitotoxicity is proposed 
Introduction 
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to be the cause of cell death is many traumatic and non-traumatic neuronal diseases 
like spinal cord injury, brain injury, stroke and neurodegenerative diseases (multiple 
sclerosis, Parkinson’s disease, Alzheimer’s disease, Amyotrophic Lateral Sclerosis 
(ALS) and Huntington’s disease).  
 
3. Cell Death Pathways 
 
Cell death after spinal cord injury involves complex heterogeneous processes that 
follow biochemical cascades which are not yet fully understood (Kroemer et al., 
2009). The nomenclature committee on cell death (NCCD) has proposed definitions 
for distinct cell death pathways in 2012. I will be discussing 3 of these pathways in 
my thesis, namely necrosis, apoptosis and parthanatos.  
 
3.1. Apoptosis 
 
Apoptosis is a normal process of cell elimination during development of white and 
grey matter of spinal cord. During the secondary spinal cord injury phase, apoptosis 
becomes more prominent than in the early phase of injury. Apoptosis can be triggered 
by cytokines, inflammation, free radicals and excitotoxicity. Emery et al. (1998) 
reported the existence of apoptosis after traumatic spinal cord injury in man. 
Apoptosis can be observed in various cell types after SCI: neurons, oligodendrocytes, 
microglia and astrocytes (Dumont et al., 2001). Morphological indicators of apoptosis 
include rounding of the cell, formation of blebs, chromatin condensation, nuclear 
fragmentation, increased intracellular Ca2+ , endoplasmic reticulum dysfunction and 
budding of apoptotic bodies (Galluzzi et al., 2012).  
 
Extrinsic pathway – this kind of apoptosis is receptor dependent and is evoked by the 
extracellular signal generated by tumor necrosis factor (TNF). It is mediated by Fas 
ligand (FasL) and Fas receptor and/or inducible nitric oxide synthase produced by 
macrophages. FasL binds to Fas receptor (Leskovar et al., 2000; Sakurai et al., 1998) 
Introduction 
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and induces a programmed sequence of caspase activation which involves caspase-8 
(inducer caspase) and caspase-3 and caspase-6 (effector caspases) (Eldadah and 
Faden, 2000). The activation of effector caspases results in cell death. The inducible 
nitric oxide synthase triggers caspase-3 cell death pathway. Extrinsic pathway in 
neurons after SCI is triggered by higher concentration of Ca2+ which induces 
mitochondrial damage, release of cytochrome c and caspase activation. The 
cytochrome c binds with apoptosis activating factor-1 to activate caspase-9 (inducer) 
and activates the effector caspases (caspase-3 and 6) to cause cell death (Budd et al., 
2000; Kuida, 2000).  
 
Intrinsic pathway - The signaling cascade for intrinsic apoptotic trigger is diverse, but 
all these signals are linked to mitochondrion-centered control mechanisms. 
Apoptosis, when initiated from inner mitochondrial membrane, develops via the 
permeability transition pore complex (PTPC). It starts on the outer membrane of 
mitochondria due to the formation of pores by the activity of BAK and BAX (BCL-2 
protein family) (Galluzzi et al., 2012). The oligomerization of BAX and BAK induces 
mitochondrial dysfunction and changes the mitochondrial membrane potential, with 
production of reactive oxygen species (ROS), formation of membrane pores leading 
to loss of mitochondrial constituents including cytochrome-c, apoptosis inducing 
factor (AIF) and endonuclease G (EndoG) (Galluzzi et al., 2012; Gross et al., 1999). 
The release of cytochrome-c into the cytosol activates the adaptor apoptotic protease 
activating factor-1 (Apaf-1) which facilitates the formation of the apoptosome (a 
caspase activating complex made up of cytochrome c, Apaf-1 and dATP) (Liu et al., 
1996). The apoptosome in turn triggers the caspase cascade involving caspase 9 and 
caspase 3 (Figure 4). AIF translocates to nucleus causing DNA fragmentation. The 
intrinsic apoptosis can be a caspase dependent or independent phase, whose relative 
contribution to cell death execution can be estimated by use of caspase inhibitors 
which may provide short term cytoprotection.  
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Figure 4. Schematic representation demonstrating intrinsic and extrinsic 
pathways of apoptosis (Kuzhandaivel et al., 2011). 
 
3.2. Necrosis 
 
Necrosis was traditionally considered as accidental cell death with no morphological 
traits of programmed cell death like apoptosis or autophagy. Nowaday, necrosis is 
believed to be programmed or regulated. Various circumstances can result in 
programmed necrosis including DNA damage, excitotoxicity, and activation of death 
receptors (Galluzzi et al., 2012). The immediate physical spinal cord injury causes 
necrosis at the injury site resulting in early death of cells. because cells swell, and an 
energy crisis arises due to mitochondrial dysfunction which leads to cytoplasmic 
membrane lysis (Cohen, 1993; Lu et al., 2000). Necrosis can be further characterized 
depending on the specificity of signaling modules. The RIP1- and/or RIP3-dependent 
Introduction 
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necrosis is regulated by RIP1 (receptor-activating protein 1) and/or RIP3 (Degterev et 
al., 2008; He et al., 2009) activation through the tumor necrosis factor receptor-1 
(TNFR1) and it produces the disintegration of mitochondria, lysosomes and plasma 
membranes. The RIF1 dependent activation can be inhibited by using an antagonist, 
neurostatin-1 (Degterev et al., 2005, 2008; Wang et al., 2007).  
 
3.3. Parthanatos  
 
The term parthanatos comes from the Greek word Thanatos, meaning death. It was a 
process first described by David and colleagues in 2009. It is a caspase-independent 
cell death pathway. Parthanatos starts by the production of poly-ADP-ribose (PAR) 
which is produced by poly-ADP-ribose polymerase-1 (PARP1) (David et al., 2009). 
The production of PARP1 is linked to the DNA fragmentation. PARP1 has four 
distinct sites; 1) two zinc zippers containing DNA-binding domain, 2) caspase 
cleavage site with nuclear localization signal (NLS), 3) an automodification domain 
for protein-protein interactions with BRCT motif, and 4) a catalytic site at C-terminal 
with NAD+-fold (Amé et al., 2004). PARP1 acts to promote cell death in the case of 
massive DNA damage. This can occur due to oxidative stress resulting in 
overproduction of nitric oxide (NO) which interacts with superoxide anion to produce 
peroxy-nitrite and causes DNA damage that activates PARP1 (Dawson et al., 1991; 
Xia et al., 1996). PARP-1 synthesizes a polymer of ADP-ribose, PAR, linked by 
glycosidic bonds. PAR synthesis was first described by Chambon et al. (Chambon et 
al., 1963). ADP-ribose is formed by hydrolysis of NAD+ and releases nicotinamide. 
The PAR polymer might be linear or branched, but it is heterogeneous in length and 
branching (one branch every 20-50 ADP-ribose residues) (D’Amours et al., 1999). 
The more complex and heavier (high molecular weight) PAR polymer is, more toxic 
it becomes (David et al., 2009). PAR, when it binds to its target protein, changes 
protein activity by functioning as site specific covalent modification, a protein 
binding matrix or a steric block (Kim et al., 2005). The over activation of PARP1  
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depletes NAD+ pools resulting in energy depletion (ATP) which results in cell death 
(Chiarugi, 2005; D’Amours et al., 1999). The over activation of PARP1 also 
facilitates the release of apoptosis inducing factor (AIF). AIF has high affinity for 
PAR through PAR binding sites. The release of AIF from mitochondria is triggered 
when PAR translocates to the cytosol from the nucleus (Andrabi et al., 2006; Wang et 
al., 2011). AIF then translocates to nucleus causing DNA fragmentation. However, 
the precise mechanism of induction of AIF by PAR is still poorly understood.  
 
 
 
 
Figure 5. Schematic representation demonstrating parthanatos pathway 
mediated by PARP1 (Kuzhandaivel et al., 2011). 
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Several studies with different models of spinal cord injury have identified the 
presence of PARP1 dependent cell death, parthanatos. Our lab has also demonstrated 
the presence of parthanatos in neuronal cells of grey and white matter after 
excitotoxicity (Bianchetti et al., 2013; Kuzhandaivel et al., 2010a, 2011; Nasrabady et 
al., 2011a). After ischemia and traumatic brain injury (TBI), oxidative stress is found 
to be the major cause of parthanatos (David et al., 2009). The pharmacological 
inhibition of PARP1 has resulted in neuronal protection in experimental models of 
stroke, ischemia, neurotrauma, excitotoxicity and Parkinson’s disease (Mandir et al., 
1999, 2000; Szabó and Dawson, 1998; Whalen et al., 1999). The schematic 
representation of the parthanatos process is shown in Figure 5. 
 
4. Heat Shock Protein (HSP) 
 
The heat shock proteins are highly conserved among all the animals and even plants. 
These chaperones perform very crucial processes in an animal’s life like maintaining 
cellular homeostasis. The expression of HSPs increases markedly under stressful 
conditions including neurodegenerative diseases (Brown, 2007). The classification of 
HSPs is based on their molecular weight, homology and function. The 70 kDa heat 
shock protein (HSP70) family is an ATP-dependent molecular chaperone (Figure 6).  
 
N C
EEVD
1 383 542 646
44 kDa 18 kDa 10 kDa
ATP Binding Domain Peptide Binding Domain
HSP70
 
 
Figure 6. Diagrammatic structure of HSP70. EEVD is the highly 
conserved sequence at the carboxy terminal. 
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HSP70 assists in the process of correct folding newly synthesized polypeptides, the 
assembly of multi-protein complexes, and the transport of proteins across cellular 
membranes under normal conditions (Boorstein et al., 1994; Kroemer, 2001; Mayer, 
2013). The synthesis of HSP70 enhances the ability of cells to cope with increased 
concentrations of unfolded or denatured proteins under various stress conditions 
(Giffard et al., 2004). Neurons are particularly vulnerable to protein misfolding and to 
intracellular accumulation of insoluble protein aggregates (Kroemer, 2001). The 
increased expression of HSP70 has neuroprotective effects in various animal models 
of neurodegenerative diseases (Brown, 2007) and this effect is dependent on its 
ability to bind AIF and to inhibit programmed cell death (Garrido et al., 2001; 
Sevrioukova, 2011). Spinal motoneurons show high levels of HSP70 in various 
neurodegenerative disease models (Brown, 2007) and after ischemia of the rat spinal 
cord (Carmel et al., 2004; Cizkova et al., 2004).  
HSP70 interacts with AIF to prevent cell death (Giffard and Yenari, 2004; Gurbuxani 
et al., 2003; Ravagnan et al., 2001; Ruchalski et al., 2006). Upon release of AIF from 
damaged mitochondria, HSP70 captures it and prevents its nuclear import. The 
peptide binding domain of HSP70 is responsible for such an interaction. HSP70 also 
interacts with the apoptotic protease-activating factor (Apaf-1). In particular, when 
cytochrome-c is released by mitochondria in response to stress, it oligomerizes with 
Apaf-1 to recruit procaspase-9 to form the apoptosome (Mosser and Morimoto, 
2004): binding of the HSP70 ATP binding-domain to Afap-1 prevents this process. 
The apoptosome formation can be inhibited in vitro by addition of purified HSP70, 
prior to the addition of cytochrome-c to the cytosolic extracts (Saleh et al., 2000). 
Furthermore, HSP70 can exert its anti-apoptotic effects upstream of caspase 
activation by blocking the caspase-3 activation. The processing of procaspase-3 is 
required for caspase 3 activation but it has been shown that over-expression of HSP70 
can inhibit it (Buzzard et al., 1998; Mosser et al., 1997). HSP70 also prevents necrotic 
cell death by interfering with reactive oxygen species (ROS) (Giffard and Yenari, 
2004). The Figure 7 summarizes the potential intrinsic targets of HSP70.  
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Figure 7. Influence of HSP70 in suppression of apoptosis, necrosis and 
parthanatos. The dotted grey lines indicate the cyclic nature of the 
pathways, resulting in DNA damage (chromatin condensation, DNA 
fragmentation), in absence of HSP70. This DNA damage results in cell 
death (indicated by grey triangle).  
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5. General Volatile Anesthetics 
 
In recent years it has been established that the spinal cord is the primary site 
responsible for the immobilization by most anesthetics. It has also been shown that 
the  isolated spinal cord preparation is the most suitable to study their action on 
motoneurons (Sonner et al., 2003). The clinically used general anesthetics are found 
to be neuroprotective in rodent model of brain ischemia (Burchell et al., 2013; 
Mackensen et al., 1999; Warner et al., 1995). One possibility for neuroprotection by 
anesthetics is inhibition of glutamate receptor mediated excitotoxicity. Volatile 
anesthetics are known to reduce glutamate release (Patel et al., 1995), glutamate 
mediated calcium influx (Bickler et al., 1994) acting through NMDA receptors (Yang 
and Zorumski, 1991) in the brain. Nevertheless, the mechanism by which these 
anesthetics operate is not completely understood.  
Earlier it was hypothesized that the action of general volatile anesthetics was based 
on nonspecific interaction with the cell membrane bilayer (Elliott et al., 1992; Franks 
and Lieb, 1994). This lead to the idea of exploring membrane bound proteins, 
particularly ion channels. The inhibitory GABA and glycine receptor channels were 
identified as targets of anesthetics (Daniels and Smith, 1993; Mihic et al., 1997). 
More recently, focus has been directed to background K+ channels that cause 
membrane hyperpolarization and increase neuronal input conductance (Sirois et al., 
2000). In particular, the functional role of TASK channels (subgroup of background 
K+ channels) has been explored in relation to the anesthetics action on rat 
motoneurons where they are abundantly expressed (Lazarenko et al., 2010). These 
TASK channels are pH sensitive and generate weakly rectifying K+ currents after 
exposure to volatile general anesthetics (Duprat et al., 1997). There are several 
reasons to believe that these channels play an important role in motoneuron function 
as well as in other neuronal populations (Bayliss et al., 2003; Lesage and Lazdunski, 
2000). A prominent K+ current in motoneurons cannot be explained by known 
presence of inward rectifying Kir2.2 and Kir2.4 channels (Karschin et al., 1996; Prüss 
et al., 2005). Among these TASK channels, TASK-1 and TASK-3 are most 
commonly expressed in the CNS (Karschin et al., 2001; Talley et al., 2001) where 
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TASK-3 channels are implicated in mitochondrial dysfunction (Bittner et al., 2010). 
The mechanism of spinal cord injury pathophysiology involves mitochondrial 
dysfunction, a process in which TASK-3 channels are implicated (Bittner et al., 
2010). Marnic et al. have found that the motoneurons in the ventral horn of cervical 
spinal cord highly expressed somatodendritic TASK-3 channels, Figure 8 (Marinc et 
al., 2012). The functional role of TASK-1 and TASK-3 channels has also been 
studied with respect to anesthetics in conditional knock-out mice in which it has been 
found that higher doses of anesthetics are required to elicit immobilization in mice 
lacking TASK-1 and TASK-3 channels (Lazarenko et al., 2010). These data suggest 
that TASK channels on motoneurons are molecular substrates to general anesthetics 
actions.   
 
 
 
 
Figure 8. Localization of TASK-3 channels in spinal cord motor neurons. 
(A) Cresyl violet staining of a spinal cord section from the cervical region. 
(B) Immunocytochemistry with the anti-TASK-3 antibody detected strong 
TASK-3 expression in motor neurons of the anterior horn. The channel 
protein can be found in somata and dendrites (see inset). Bar represent 1 
mm in (A), and 500 µm in (B) (Marinc et al., 2012). 
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These considerations suggest the desirability of investigating the influence of a 
general anesthetic on the mechanisms of spinal injury. For this purpose, the physical 
and chemical properties of the volatile anesthetic methoxyflurane (Andersen and 
Andersen, 1961) makes it a suitable candidate for further exploration. 
Methoxyflurane possesses a number of effects, such as activation of the calcium 
dependent ATPase in the sarcoplasmic reticulum via increased fluidity of lipid bilayer 
(Elliott et al., 1992).  
GABA and glycine receptors are both ligand-gated ion channels. The GABA 
receptors are heteromeric complexes formed by assemblies of different glycoprotein 
subunits, whereas glycine can be heteromeric (complexes of alpha subunits) or 
homomeric (complexes of alpha and beta subunits). Methoxyflurane also binds to 
GABA receptors to produce the depressant effects (Moody et al., 1988) via GABA 
mediated chloride channels. It was shown that GABA antagonist Ro15-4513 blocked 
the effect of methoxyflurane in mice whereas GABA inverse agonists had no effect 
on methoxyflurane induced sleep time in mice (Moody and Skolnick, 1988). The 
effects of volatile general anesthetics on glycine receptors were found to be sensitive 
to ether, alkane and alcohol but not to other anesthetics like etomidate, propofol, 
barbiturates, alpha-chloralose and steroidal anesthetics in various animal models and 
cell lines (Koltchine et al., 1996; Krasowski and Harrison, 2000; Mascia et al., 1996; 
Pistis et al., 1997; Prince and Simmonds, 1992). Glutamate is an excitatory 
neurotransmitter and its postsynaptic actions are mediated by a variety of receptors. 
The NMDA glutamate receptor opens a non-selective cation channel characterized by 
high Ca2+ permeability (Seeburg, 1993) and glycine is an NMDA receptor co-agonist 
(Kaplita and Ferkany, 1990). Several studies suggest the interaction between NMDA 
receptor and volatile general anesthetics. The potency of volatile anesthetics is shown 
to be increased by the  NMDA receptor antagonist MK-801 in rat brain (Foster et al., 
1987). Isoflurane blocked NMDA mediated currents by decreasing the frequency of 
channel opening and mean channel opening time in rat cultured hippocampal neurons 
(Yang and Zorumski, 1991). In another study performed with radioligand binding 
assay (membrane cells were obtained from rat cerebral cortex), the effects of volatile 
general anesthetics on NMDA receptors showed antagonist (MK-801) binding to be 
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markedly inhibited by volatile general anesthetics in non-competitive manner: glycine 
reversed most of the inhibition (Martin et al., 1995).  
 
6. Therapeutic Approaches - Past, Present and Future 
 
Progressive tissue degeneration initiates in the secondary phase of spinal cord injury, 
but, at the same time, it also prompts a number of neuroprotective and regenerative 
responses. Regenerating axons can be observed within the first 24 h after injury 
(Kerschensteiner et al., 2005), a process is known as abortive sprouting (Hill et al., 
2001; Schwab and Bartholdi, 1996) because it does not lead to any major 
improvement on its own. Spontaneous remyelination can also occur in Schwann cells 
and oligodendrocytes after axonal demyelination (Gilson and Blakemore, 2002). 
Spontaneous behavioral improvement can be observed perhaps due to functional 
plasticity and local circuit formation or adaptation, a phenomenon typically reported 
in rodents and humans after incomplete spinal cord injury (Bareyre et al., 2004; 
Edgerton et al., 2004; Frigon and Rossignol, 2006). Neurorehabilitation can also play 
an important role in recovering locomotor network after injury (Baptiste and 
Fehlings, 2007). Here I will be discussing three major therapeutic approaches to the 
acute phase of spinal cord injury. 
 
6.1. Neuroprotection 
 
The minimization of secondary damage after injury has been attempted many times 
with the help of various pharmacological substances (Kwon et al., 2011; Schwab et 
al., 2006), often adapting strategies employed for brain stroke.  
 
Lipid Peroxidase Inhibition - The most studied substance in this regard is 
methylprednisolone (MP) as, in high doses, it was used to inhibit post traumatic lipid 
peroxidation (Braughler and Hall, 1981). MP is thought to reduce the inflammation, 
formation of a cytotoxic edema, the release of glutamate and formation of free 
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radicals. However, certain side effects, (like facilitated infection, delayed wound 
healing, diabetic complications and septic shock) have been reported for the high 
dose of MP in humans, making its clinical use still controversial.  
 
Calcium Channel Blocker - Nimodipine is an L-type calcium channel blocker. Since 
excitotoxic glutamate release is calcium dependent, this drug is thought to be 
neuroprotective against subarachnoid hemorrhage (Fehlings et al., 1989). 
 
Anti-inflammatory Agents – Because the inflammatory response after spinal cord 
injury has profound effects on the spinal cord, anti-inflammatory agents have been 
tested as neuroprotective. In particular, COX2 inhibitors and the antioxidant 
resveratrol have been used as anti-inflammatory substances. Studies have shown 
neuroprotection after reseveratrol in an experimental stroke model (Baur and Sinclair, 
2006).  
 
Erythropoietin - Another, rather new, neuroprotective substance is erythropoietin, an 
endogenous hormone normally responsible for increased red blood production via 
maturation of reticulocytes. It has been shown to increase spared tissue and decreased 
the cavity volume size at injury site in rats along with some neuronal regeneration 
(Huang et al., 2009). The recovery of hindlimb motor function after contusive spinal 
cord injury has been observed in rats by acute administration of recombinant human 
erythropoietin and it was suggested that the locomotor recovery was the result of 
erythropoietin mediated sparing of spinal cord sensory and motor pathways (Cerri et 
al., 2012).  
 
Neurotrophic Factors - Neurotrophic factors like neurotrophin 3 and 4 (NT-3 and 
NT-4), brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) 
have all shown therapeutic potential for spinal cord injury (Blesch et al., 2002; 
Schnell et al., 1994). However, they are not sufficient on their own because they 
cannot help injured nerve fibres to overcome the axon growth inhibitory environment 
created after spinal cord injury. They rather seem to be more useful in combination 
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with other treatment strategies to contribute to functional recovery (Fouad et al., 
2005; von Meyenburg et al., 1998).  
 
Inhibitory-factor Blockers – In recent years, new approaches to surmount the negative 
action of myelin derived inhibitors that impede regrowth have shown interesting 
preclinical results after spinal cord injury. Schnell and Schwab have reported the first 
attempt to promote regeneration with a monoclonal antibody against NogoA (Schnell 
and Schwab, 1990). Recently, clinical trials with the humanized NogoA antibody 
have been started (Buchli et al., 2007). This substance act on the GTPase Rho which 
inhibits regeneration (He and Koprivica, 2004): its antagonists (Cadotte and Fehlings, 
2011) may be neuroprotective by increasing regeneration and functional recovery 
after spinal cord injury (Dergham et al., 2002). 
 
Sodium Channel Blocker - Excitotoxicity is the result of glutamate hyperactivity and 
use of glutamate inhibitors/antagonists might lead to some neuroprotection. CNQX 
and APV, when coapplied with kainate, have produced partial protection of 
locomotor networks in an in vitro rat model of spinal cord injury as NMDA and 5HT 
have elicited fictive locomotion in 1/3 of preparation (Margaryan et al., 2010). 
However, only few oscillatory cycles have been observed after a train of DR pulses 
with some recovery of cumulative depolarization (Margaryan et al., 2010). It is 
suggested that the slow pharmacokinetics of CNQX and APV require a long time to 
block glutamate receptor of rat spinal cord (Long et al., 1990) that is significantly 
later of the glutamate receptor hyperactivity. Another such substance is riluzole, that 
is a sodium channel blocker already approved for symptomatic use in patients with 
amyotrophic lateral sclerosis (ALS) (Kitzman, 2009; Schwartz and Fehlings, 2001; 
Springer et al., 1997). Clinical trials with riluzole are underway for spinal 
neuroprotection after acute traumatic spinal cord injury (Wilson and Fehlings, 2014). 
Riluzole apparently exerts its neuroprotective effects by blocking voltage sensitive 
sodium channels. In addition, riluzole antagonizes presynaptic calcium dependent 
glutamate release. When riluzole is used in combination with methylprednisolone, it 
is claimed to reduce oxidative stress by improving mitochondrial function and 
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enhancing glutamate uptake (Mu et al., 2000). Our laboratory has reported minimal 
neuroprotective effects of riluzole on locomotor networks after excitotoxic spinal 
cord injury (Sámano et al., 2012) with more encouraging results on spinal 
organotypic cultures (Mazzone and Nistri, 2011a).  
 
PARP1 Inhibitors - The role of PARP1 in excitotoxicity induced cell death has 
already been discussed. In recent years, our laboratory has been exploring the 
possibilities to improve neuroprotection by using PARP1 inhibitors (Kuzhandaivel et 
al., 2010a; Nasrabady et al., 2011a, 2011b, 2012). The isolated neonatal spinal cord 
has shown decreased number of pyknotic cells after use of pharmacological inhibitor 
of PARP1 by PHE (6-5(H)-phenanthiridinone) following kainate induced 
excitotoxicity (Kuzhandaivel et al., 2010a). Another potent PARP1 inhibitor is PJ34 
(2-(dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2yl)acetamide). It exerts 
significant neuroprotection against acute stroke even if given as late as 10 minutes 
prior to reperfusion time (Abdelkarim et al., 2001). Studies in our laboratory have 
also shown PJ34 to be moderately neuroprotective in spinal cord injury models with 
some recovery of locomotor network activities (Mazzone and Nistri, 2011b; 
Nasrabady et al., 2011b, 2012).  
 
Heat Shock Proteins – The increased expression of HSP70 has neuroprotective 
effects in various animal models of neurodegenerative diseases (Brown, 2007) and 
this effect is dependent on its ability to bind AIF and to inhibit programmed cell death 
(Garrido et al., 2001; Sevrioukova, 2011). Spinal motoneurons show high levels of 
HSP70 in various disease models ( Brown, 2007; Carmel et al., 2004; Cizkova et al., 
2004). HSP70 has been shown to neuroprotect motoneurons against ALS 
degeneration (Gifondorwa et al., 2007) and oxidative stress (Robinson et al., 2008) in 
a mouse model. The use of enhancers for HSP70 like celestrol has proved to be 
neuroprotective in differentiated human neurons (Chow and Brown, 2007). HSP70 
has also been tested on knockout (KO) mice and the decreased level of functional 
recovery was observed in KO when compared to wild type mice after spinal cord 
injury (Kim et al., 2010).  The HSP70 inhibitor VER155008 ( 5'-O-[(4-cyanophenyl) 
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methyl]-8- [[(3,4-dichlorophenyl) methyl]amino]-adenosine) (William-son et al., 
2009) is known to antagonize the neuroprotective action of HSP70 after mild 
traumatic brain injury (Saykally et al., 2012). These data indicate that exploring the 
role of HSP70 for spinal cord injury treatments can be fruitful. 
 
General Anesthesia with gas anesthetics - Volatile anesthetics depress reflex activity 
by suppressing excitability of spinal motoneurons in rats (Collins et al., 1995). 
Furthermore, volatile anesthetics are known to be neuroprotective against 
excitotoxicity in the brain (Kudo et al., 2001; Popovic et al., 2000; Ren et al., 2014) 
and spinal cord  (Nout et al., 2012). Anesthetics like isoflurane and urethane have less  
deleterious effects (compared to propofol, morphine, pentobarbital and alpha-
chloralose) on outcomes of induced injury when used either during the lesion 
procedure or postoperatively in a brain injury models (Cochrane et al., 1988; 
O’Connor et al., 2003; Statler et al., 2000, 2006a, 2006b). For spinal cord injury 
models, halothane has resulted is better neurological outcomes compared to other 
anesthetics like ketamine and pentobarbital (Grissom et al., 1994; Ho and Waite, 
2002; Leal et al., 2007; Salzman et al., 1990), indicating neuroprotective effects of 
general volatile anesthetics during neurosurgery. Likewise, when isoflurane was 
administered during a study of rat spinal cord injury, it facilitated the recovery of 
locomotor function much better than pentobarbital (Nout et al., 2012). These studies 
suggest that the choice of general anesthetic has an impact on the outcome of 
experiments and can be a good neuroprotective strategy.  
 
6.2. Neurorepair 
 
After spinal cord injury, cell transplantations have been investigated to replace lost 
tissue components, remyelinate denuded axons, provide guidance structures and 
express growth factors. The cell types tested for this purpose were embryonic stem 
cells (McDonald et al., 1999), Schwann cells (Kuhlengel et al., 1990), olfactory 
ensheathing cells (Li et al., 1997) and marrow stromal cells (Chopp et al., 2000; 
Hofstetter et al., 2002). Embryonic stem cells can allegedly differentiate into 
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oligodendrocytes, astrocytes and neurons once transplanted into the injured spinal 
cord (Harper et al., 2004; Kerr et al., 2003; McDonald et al., 1999). Nevertheless, this 
is a controversial issue and the challenge in cell transplantation remains survival, 
differentiation and integration (Enzmann et al., 2006).  
The most studied cell type for transplantation after spinal cord injury is the Schwann 
cell. These cells can produce a cocktail of axonal growth factors like NGF, NT-3, 
GDNF, BDNF and FGF (Oudega and Xu, 2006). In addition to these growth factors, 
they express axon guidance cell adhesion molecules on their surfaces (Daniloff et al., 
1989). After spinal cord injury, Schwann cells are reported to reduce the size of spinal 
cysts, remyelinate axons and enhance function recovery (Baron-Van Evercooren et 
al., 1992; Xu et al., 1995).  
The other cell types that can be transplanted are olfactory nerve cells as they have the 
ability to regenerate throughout life. The olfactory ensheathing cells have been 
reported to facilitate axonal growth and functional recovery when transplanted into 
the injured medulla oblongata or spinal cord (Li et al., 1997; Ramón-Cueto and 
Nieto-Sampedro, 1994; Ramón-Cueto et al., 1998).  
The central nervous system axons can grow over long distances as long as the right 
environment is provided. Certain bridging strategies like peripheral nerve bridge 
transplantation have been shown to partially restore function in the completely 
transected spinal cord (Cheng et al., 1996; Tsai et al., 2005). All together combination 
of nerve grafts with other transplants (Schwann cells and olfactory ensheathing cells; 
Fouad et al., 2005) or substances (chondroitinase) have been described as more 
effective in recovering functionality.  
A new, interesting method for neurorepair is the use of nanoparticals/tubes for 
targeted drug delivery to spinal lesion sites. Studies on nanodrug delivery after spinal 
cord injury are not well characterized owing to the problem of maintaining high 
concentration of active drug within spinal cord to achieve neuroprotection. 
Methylprednisolone has been administered using nanoparticles of poly-lactic-co-
glycolic acid applied topically over the injured spinal cord and it has seemingly 
resulted in regeneration and functional recovery even after 7 days of primary insult 
(Chvatal et al., 2008). In another study, titanium nanowires were used to deliver drugs 
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in order to study the drug effects on pathophysiology and functionality after spinal 
cord injury in rats: this approach showed good neuroprotection only when drugs were 
delivered within 30 minutes from injury (Tian et al., 2012). A lot of research is still 
necessary to clarify this subject.   
 
6.3. Neurorehabilitation and Plasticity 
 
Neurorehabilitation has been an established treatment after spinal cord injury. For 
instance, complications like urinary tract infections can be minimized with physical 
activity. Neurorehabilitation is also helpful in improving cardiovascular function and 
patients wellbeing (Curtis et al., 1986; Hicks et al., 2003, 2005). One procedure is 
body weight support during treadmill training that can improve function in both 
rodents and humans (Lünenburger et al., 2006; Rossignol, 2000). The rationale stems 
from the realization that local spinal cord circuits, even in the absence of supraspinal 
inputs, can be modulated to produce movement patterns (Grillner, 2002). While 
spontaneous recovery after spinal cord injury can be accounted for by plasticity of 
remaining fibers (Wolpaw and Tennissen, 2001), the spinal cord can learn specific 
motor tasks with improved performance through training (Edgerton et al., 2004). 
Stepping and standing are therefore facilitated (Edgerton et al., 2001; De Leon et al., 
1999). Other rehabilitation procedures like running wheels, environmental enrichment 
and robotic devices have been used in rodent models (Engesser-Cesar et al., 2005; 
Lankhorst et al., 2001). Better understanding of mechanism for adaptation and 
plasticity after spinal cord injury is needed to devise new strategies. Another form of 
therapy that can activate neural components after incomplete spinal cord injury is 
electrical current stimulation (Grahn et al., 2014). The use of electrical stimulation to 
test the function of nervous system was first introduced by an Italian physician and 
scientist Luigi Galvani (1792) in frog legs (Parent, 2004). This kind of treatment can 
cause muscles to contract which can help restoration of motor function (Jackson and 
Zimmermann, 2012). 
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7. Spinal Cord Injury Models 
 
The spinal cord injury models have evolved over the past decades and have 
contributed to a better understanding of the injury. Rats are the most commonly used 
animals as they are inexpensive, readily available and have similar functional and 
morphological characteristics of injury when compare to humans. The injury models 
can be classified as contusion, compression, distraction, dislocation, transaction or 
chemical. A transient acute injury of the spinal cord can be induced by contusion 
methods such as weight drop (Scheff et al., 2003), electromagnetic impactor (Stokes, 
1992) and air gun device (Marcol et al., 2012). Compression models usually include 
contusion-compression processes in the sense that they involve an acute impact 
followed by prolonged compression of the spinal cord. However, compression is 
distinct from mere contusion because it implies lasting pressure analogous to the one 
of spinal fractures. Compression models include clips (Rivlin and Tator, 1978), 
calibrated forceps (Blight, 1991), and balloon compression (Tarlov et al., 1953) as 
well as spinal cord strapping (da Costa et al., 2008). The aim of the distraction model 
is to stimulate the tension forces present in the cord after spinal cord injury. 
Distraction method involves the stretching of spinal cord (Silberstein and McLean, 
1994). The most sophisticated modeling of this method is known as Harrington 
distraction (Dabney et al., 2004) and involves laminectomy at the intended injury 
location. This method has not been validated in humans yet. Dislocation models 
mimic the column shift observed after traumatic human spinal cord injury (Fiford et 
al., 2004). It was developed on rats for vertebral displacement. The other model is 
transection that could be partial or complete (Spillmann et al., 1997). Transection is 
used to study neuronal regeneration after spinal cord injury. 
Chemical models are used where secondary injury mechanism/pathways are to be 
studied after spinal cord injury. The ischemia followed by spinal cord injury can be 
induced by injections or direct application of photosensitive dyes (Watson et al., 
1986). Oxidative stress is produced by reagents like superoxide, hydroxyl radical and 
peroxynitrate (Bao and Liu, 2002). Zymosan and phospholipase A2 can be used to 
mimic inflammatory response after spinal cord injury (Liu et al., 2006). Twenty % of 
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chronic spinal cord injury cases are accompanied by syringomyelia (fluid filled cavity 
formation) which can be recreated by use of kaolin or quisqualic acid injections into 
the spinal cord (Lee et al., 2005). Excitotoxic injury can be produced by glutamate, 
aspartate, NMDA or kainate (Liu et al., 1999; Taccola et al., 2008). 
 
7.1. Our Laboratory In Vitro Neonatal Spinal Cord Injury Model  
 
Cell lines or primary cultures can be used to study cell death and neuroprotection 
mechanisms for preclinical screening, but these models do not allow testing network 
activity/function like locomotor-like activity. The in vivo models pose some serious 
concerns as the use of anesthetics administered before and during the lesion 
procedure can attenuate the severity of damage, there is usually lack of intensive care 
for experimental animals after injury, and the difficulty in inducing a non-traumatic 
lesion without affecting the general metabolic state of animal. To overcome these 
problems, our laboratory has recently developed a novel model of acute spinal cord 
injury in vitro based on the neonatal rat isolated spinal cord (Taccola et al., 2008). 
This method is equally helpful in studying non-traumatic and incomplete spinal cord 
injury (Kuzhandaivel et al., 2010a, 2010b; Nasrabady et al., 2011b; Taccola et al., 
2008). This model allows exploring the pathophysiology of spinal cord injury over 
the 24 hours by monitoring the changes in locomotor function and relating them to 
molecular and cellular alterations within spinal networks (Nistri, 2012). We have 
used this model to induce excitotoxic damage by use of kainate (Mazzone et al., 
2010; Nasrabady et al., 2011a; Shabbir et al., 2014) and ischemic injury by 
application of pathological medium characterized by oxygen-glucose deprivation 
(Bianchetti et al., 2013; Margaryan et al., 2009). The basic protocol starts with 1 hour 
application of kainate/pathological medium followed by 24 hour washout in kreb’s 
solution at room temperature. Sham preparations are kept for 24 hour without any 
toxic medium application. Although this model has some obvious limitations like lack 
of vascular supply, absence of an immune system and the rat neonatal age, it has the 
great advantage of correlating the outcome of injury after 24 hours by monitoring 
locomotor like activity (fictive locomotion) in relation to number, type and 
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topography of damaged or dead cells. It also allows the preservation of the tissue for 
further immunological and molecular studies as the extent of loss of 
electrophysiological function depends on the extent of neuronal damage (Nistri et al., 
2010).  
  
8. Central Pattern Generator (CPG) 
 
The ability to move depends on the locomotor rhythmic behavior of that specie such 
as flying, swimming or walking (Büschges et al., 2011). The inherent complexity of 
the central nervous system (CNS) in mammals has led to the studies involving 
vertebrate models with relatively fewer neurons like the lamprey (Grillner et al., 
1998) and the zebra fish (Kyriakatos et al., 2011). Vertebrates share many similarities 
in locomotor behavior and controlling system (Grillner, 1985; Grillner et al., 1977) 
because the same centers initiate locomotor activity in lampreys as in primates 
(through the activity of lower brainstem reticulospinal neurons). This system activates 
localized spinal neuronal networks which generate the timing and pattern of complex, 
rhythmic, coordinated muscle activities (Goulding, 2009). Grillner et al. (1998) 
described the controlling system of locomotion that is prevented by a tonic inhibitory 
system induced by basal ganglia (Figure 9). The descending excitatory inputs can 
therefore stimulate the local circuits to produce rhythmic alternating motor commands 
to limb muscles without the need for peripheral inputs. Thus, this system is termed 
locomotor central pattern generator (CPG). The activity of CPG network is directly 
proportional to the speed of locomotion. In addition to descending signals from 
reticulospinal projection neurons, the CPG can be activated by pharmacological 
excitatory substances or by patterned sensory inputs under experimental conditions 
(Kjaerulff et al., 1994; Marchetti and Nistri, 2001; Marchetti et al., 2001; Taccola and 
Nistri, 2006).  
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Figure 9. Schematic representation of locomotion general controlling 
system in vertebrates (Grillner et al., 1998). 
 
 
More recently a two-level structure of the CPG at spinal level has been proposed, 
comprising a rhythm generator (RG) that distributes regular rhythmic commands to a 
pattern formation circuit responsible for the correct motoneuron activation in terms of 
flexor and extensor discharges on bioth sides of the body (McCrea and Rybak, 2008).  
 
8.1. Localization of CPG Network 
 
The rostrocaudal extent of rhythmogenic capacity of the hindlimb locomotor CPG 
was proposed first by Grillner and Zangger (Grillner and Zangger, 1979). They 
demonstrated that alternating rhythmic activity could be evoked in ankle flexors and 
extensors, when the caudal lumbar cord (L6–S1 segments) was isolated from the rest 
of the spinal cord by using transverse sectioning. They suggested that the 
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rhythmogenic capacity of the CPG controlling hindlimb locomotion to be distributed 
throughout the lumbar enlargement (L3–S1 in cats). Similar results were obtained 
when other laboratories studied spontaneous or drug induced rhythmic activity before 
and after transverse trans-sectioning at different spinal levels (Bracci et al., 1996; 
Christie and Whelan, 2005; Kjaerulff and Kiehn, 1996; Kudo and Yamada, 1987). 
L1–L3 in rodents and L3–L5 in cats (rostral lumbar segments) have a greater ability 
to generate rhythmic motor output in isolation than caudal segments (L4–L6 and L6–
S1, respectively). These studies therefore suggest that the CPG is distributed along 
the lumbar cord but its excitability has a rostrocaudal gradient. The reason can be the 
larger proportion of intraspinal inputs reaching more rostral segments (Berkowitz, 
2004) and/or the differential distribution of neuronal receptors for neuromodulatory 
substances in the rostral or caudal cord (Christie and Whelan, 2005). Thus, it has been 
suggested that spinal interneurons directly involved in producing rhythmic activity 
are limited to the T13 and L2 (Kiehn, 2006). Transverse distribution of CPG in spinal 
cord was studied by activity-labeling studies (Dai et al., 2005; Kjaerulff et al., 1994) 
and multi-electrode recording (Tresch and Kiehn, 1999). It was reported that 
rhythmogenic CPG neurons are located ventrally (laminae VII, VIII, and X). It has 
also been confirmed with dorsal horn ablation studies, demonstrating the presence of 
fictive locomotion (chemically induced by NMDA and 5-HT) by recording from VRs 
(Taccola and Nistri, 2006). 
 
8.2. Elements of CPG Network 
 
The same side of the body needs both excitatory and inhibitory networks for the 
alternation between flexor and extensor motoneuron pools (Kiehn, 2006). The model 
that has been suggested for mammalian locomotor CPG has a rhythm generating layer 
(flexor-extensor) and a pattern generating layer (left-right side) (Kriellaars et al., 
1994; Lafreniere-Roula and McCrea, 2005). This model suggests that the pattern-
generating neurons are connected monosynaptically to motor neurons, whereas the 
neurons in the rhythm generating layer have two or more synapses upstream from 
motor neurons and project directly to pattern-generating neurons. The origin of 
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rhythm generation in lamprey CPG is the result of ipsilateral excitatory glutamatergic 
interneurons (Grillner, 2003). These interconnected excitatory neurons seem to work 
as burst generating units. They provide a rhythmic, excitatory glutamatergic synaptic 
drive to motor neurons and other ipsilateral inhibitory and left-right coordinating 
CPG neurons in each segment. It has been proposed that excitatory CPG neurons 
might have some intrinsic pacemaker-like properties due to the presence of rhythmic 
activity after blocking of inhibitory system (Smith et al., 2000).  
The other two elements of the network are flexor-extensor coordinating circuits and 
left-right coordinating circuits. The flexor-extensor coordination involves ipsilateral 
inhibitory networks since flexors and extensors are activated synchronously in the 
presence of synaptic inhibition block (Beato and Nistri, 1999; Cowley and Schmidt, 
1997). 
The right-left coordinating circuitries have been studied mostly in mammals to show 
that these complex circuitries consist of intrasegmental (binding motor synergies 
along the spinal cord) and intersegmental (coordinate homonymous muscle activity at 
segmental level) commissural interneurons (CINs). The CINs are both inhibitory and 
excitatory. Thus, the functioning of CPG network in proposed to operate by 
contribution of excitatory neurons responsible for rhythm generation and glycinergic 
CINs, that are directly involved in left-right alterations (Kiehn, 2006, 2011).    
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Figure 10. Organization of left–right coordinating CPG circuits in 
rodents. The core of the left–right system in rodents is composed of 
commissural interneurons (CINs) acting directly via inhibitory CINs 
(CINi), or indirectly, via excitatory CINs (CINei) on contralateral motor 
neurons (MN). This system is involved in left–right alternation. Left–right 
synchrony is obtained via a single excitatory system (CINe) acting directly 
on motor neurons. To obtain left–right coordination during locomotion, 
these crossed connections should also connect to the rhythm-generating 
core (indicated with dotted lines) on the other side of the cord and/or 
corresponding commissural interneurons. A single neuron in the diagram 
represents a group of neurons. Inhibitory interneurons are blue. 
Excitatory interneurons are red, and motor neurons green. Dotted line 
indicates the midline. Abbreviations: IINi: ipsilaterally projecting 
inhibitory interneuron. RC: Renshaw Cell. MN: motor neuron (Kiehn, 
2011).  
 
 
Multiple neuronal subtypes are involved in the different aspects of left-right 
coordination.  The interneurons play important role in the operation of the neuronal 
circuitry. Ventral progenitor cells are the ones to give rise to motoneurons and 4 
classes of interneurons (V0 – V3) (Rabe et al., 2009; Zhang et al., 2014). Among 
them, V0 and V3 give rise to CINs that are studied to understand the genetic basis of 
locomotor coordination. V0 neurons are mostly inhibitory (Lanuza et al., 2004) 
whereas V3 are predominantly excitatory (Bernhardt et al., 2013). V2 interneurons 
comprise two subpopulations; one expressing Chx10 and Lhx3 and the other 
expressing Gata2 and Gata3 (Karunaratne et al., 2002; Smith et al., 2002). The 
ablation of Chx10 and Lhx3 results in high variability of cycle period and amplitude 
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of locomotor bursts (Crone et al., 2008) during fictive locomotion. The other 
important factor is correct axonal guidance during the formation of the functional 
neuronal circuitry. There are four families of axonal guides with their receptors which 
have been identified in recent years, namely ephrin-Eph (Imondi et al., 2000), Slits-
Robo (Brose and Tessier-Lavigne, 2000), semaphorins (neuropilin and plexin co-
receptors) (Castellani and Rougon, 2002) and netrins with DCC, Unc-5/RCN and 
neogenin receptors (Barallobre et al., 2005; Tessier-Lavigne and Goodman, 1996).  
 
8.3 Fictive Locomotion 
 
The term fictive swimming in lamprey spinal cord was introduced by Grillner and 
colleagues (Grillner et al., 2001) and the corresponding mechanism is the mammalian 
isolated spinal cord is known as fictive locomotion (FL). The fictive locomotion is 
product of CPG networks and is produced by rhythmic alternating oscillations 
between left-right and flexor-extensor motor pools. In an isolated spinal cord 
preparation, fictive locomotion can be elicited chemically and/or electrically. The 
chemically induced FL can be achieved by application of certain drugs like NMDA 
and serotonin (5HT). These pharmacological agents raise spinal network excitability 
to activate a sufficient number of CPG neurons (Christie and Whelan, 2005; Grillner 
et al., 2001; Kjaerulff and Kiehn, 1996). Electrical stimulation can be applied by train 
of stimuli to a single dorsal root (DR) which can be recorded from left- right L2 
ventral roots (VRs; flexor motor pool commanding hindlimb) and left-right L5 VRs 
(extensor motor pool commands to hindlimb) (Nasrabady et al., 2011b; Nistri et al., 
2010; Taccola et al., 2004, 2008). Similar activity can be observed when electrical 
stimulation is applied in vivo animals and to spinal cord injury people. In humans 
with complete spinal cord injury, epidural stimulation at the level of T11 – L1 elicits 
locomotor-like EMG activity (Dimitrijevic et al., 1998).  
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9. Field Potential 
Motoneurons are an essential component of locomotor network activity and many of 
them can survive after spinal cord injury. While studies conducted on motoneurons at 
single cell level provide important information on cell properties, the response of 
more than one motoneuron is required when investigating the functional outcome of 
any neuroprotective therapy. Field potential (FP) recordings can show the collective 
behaviour of the motoneuronal population in the ventral motor area. Further, the 
advantage of FP recording is that they can more easily be obtained than intracellular 
or whole cell recording and are much more stable for long term investigations. 
Recording evoked field potentials is a widely applied technique in vitro (Bear et al., 
1992; Fulton and Walton, 1986; Zhou and Poon, 2000) and in vivo (Berger and 
Averill, 1983).  
The extracellular potentials induced by electromotive force of excitable membranes 
are called field potentials (FPs). The potential (and current) fields at any point in the 
extracellular medium are given by the sum of signals resulting from each active 
current component entering (source) and leaving (sink) the recorded site. As a result, 
the net balance of all the currents that flow into a small extracellular local volume 
represents the field potential (Zhou and Poon, 2000). Any excitable membrane (spine, 
dendrite, soma, axon or axon terminal) and any type of transmembrane current can 
contribute to the field potentials that are the expression of all the ionic processes 
ranging from fast action potentials to the slow fluctuations in glia. The amplitude of 
the field potential is inversely proportional to the distance of the recording electrode 
from the current source. The distance also leads to inclusion of other interfering 
signals. The field potentials can come from multiple sources such as synaptic activity 
(fast sodium action potential), calcium spikes, and intrinsic currents (Buzsáki et al., 
2012). Many extracellular currents must overlap to give a measurable signal as 
synaptic activities are slow events (Elul, 1971; Logothetis and Wandell, 2004). The 
excitatory currents are mediated by neurotransmitters acting on NMDA and AMPA 
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receptors, whereas GABA (and glycine) receptors mediate inhibitory currents. In 
general, inhibitory currents contribute little to field potentials (Bartos et al., 2007).  
In the present study, they provide the average strength of the motoneuronal pool 
activation in the ventral horn of the spinal cord. The evoked field potentials are 
stimulus intensity dependent, their amplitude increases with increasing stimulus as 
shown in Figure 10. At high stimulus voltage, the response gets saturated and an 
artifact can over-shadow the potential. 
 
 
 
 
 
Figure 10. Effects of stimulus intensity on field potential 
(Zhou and Poon, 2000). 
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Aims of the Study 
 
During the early phase of spinal cord injury, neuroprotective interventions can be 
extremely important to determine the injury outcome by preventing delayed 
pathological events. Thus, in relation to this issue, two main questions were 
investigated in the present project. First, can a volatile general anesthetic protect the 
spinal cord? This enquiry is prompted by the observation that volatile general 
anesthetics are neuroprotective in many injury models of the CNS probably because 
these agents inhibit the excitotoxicity induced glutamate release. Second, since a 
number of motoneurons survive the first insult, what endogenous mechanisms are 
used by such cells to withstand damage, and do they remain functional? Using the in 
vitro model of neonatal spinal cord injury, the aims of the present study are: 
 
• Potential neuroprotective effect of the volatile general anesthetics 
Methoxyflurane on; 
 
1. Motoneurons survival and their functional outcomes. 
2. Electrophysiological properties of CPG network activity. 
 
I further enquired what intrinsic mechanism might be involved in motoneuron 
survival after spinal cord injury with the goal to understand: 
 
• The role of heat shock protein 70 (HSP70) in spinal cell survival by studying: 
 
1. Expression of HSP70 and AIF in motoneurons after excitotoxicity. 
2. Pharmacological inhibition of HSP70 by VER155008 and its consequences on 
cell survival and electrophysiological properties.  
Materials, methods and results 
______________________________________________________________________________________ 
 42 
 
 
 
 
 
 
 
 
Materials, methods and results 
 
Section I 
 
The volatile anesthetic methoxyflurane protects motoneurons against excitotoxicity in 
an in vitro model of rat spinal cord injury.  
 
Ayisha Shabbir, Elena Bianchetti, Andrea Nistri (2015). 
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THE VOLATILE ANESTHETIC METHOXYFLURANE PROTECTS
MOTONEURONS AGAINST EXCITOTOXICITY IN AN IN VITRO MODEL
OF RAT SPINAL CORD INJURY
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Neuroscience Department, Scuola Internazionale Superiore di
Studi Avanzati (SISSA), Trieste, Italy
Abstract—Neuroprotection of the spinal cord during the
early phase of injury is an important goal to determine a
favorable outcome by prevention of delayed pathological
events, including excitotoxicity, which otherwise extend
the primary damage and amplify the often irreversible loss
of motor function. While intensive care and neurosurgical
intervention are important treatments, effective neuroprotec-
tion requires further experimental studies focused to target
vulnerable neurons, particularly motoneurons. The present
investigation examined whether the volatile general anes-
thetic methoxyflurane might protect spinal locomotor net-
works from kainate-evoked excitotoxicity using an in vitro
rat spinal cord preparation as a model. The protocols
involved 1 h excitotoxic stimulation on day 1 followed by
electrophysiological and immunohistochemical testing on
day 2. A single administration of methoxyflurane applied
together with kainate (1 h), or 30 or even 60 min later pre-
vented any depression of spinal reflexes, loss of motoneu-
ron excitability, and histological damage. Methoxyflurane
per se temporarily decreased synaptic transmission and
motoneuron excitability, effects readily reversible on wash-
out. Spinal locomotor activity recorded as alternating electri-
cal discharges from lumbar motor pools was fully preserved
on the second day after application of methoxyflurane
together with (or after) kainate. These data suggest that a vol-
atile general anesthetic could provide strong electrophysio-
logical and histological neuroprotection that enabled
expression of locomotor network activity 1 day after the exci-
totoxic challenge. It is hypothesized that the benefits of early
neurosurgery for acute spinal cord injury (SCI) might be
enhanced if, in addition to injury decompression and stabil-
ization, the protective role of general anesthesia is exploited.
Ó 2014 IBRO. Published by Elsevier Ltd. All rights reserved.
Key words: spinal locomotor network, fictive locomotion,
motoneurons, spinal reflex.
INTRODUCTION
Although the majority of new cases of spinal cord injury
(SCI) are associated with an incomplete lesion, severe
locomotor deficit usually ensues with resultant paralysis
and uncertain recovery (McDonald and Sadowsky,
2002; Nair et al., 2005; van den Berg et al., 2010). One
essential factor for this negative outcome is the extension
of the primary lesion over the first few hours and days to
surrounding spinal areas (secondary lesion) (Sekhon and
Fehlings, 2001; Park et al., 2004; Rowland et al., 2008).
Hence, it is important to protect, with various strategies
(Boulenguez and Vinay, 2009), initially-spared nervous
tissue from further damage which, according to experi-
mental preclinical data, might be already complete within
the first 24 h (Mazzone and Nistri, 2014). One major
mechanism for lesion progression is excitotoxicity
whereby sustained activation of glutamate receptors
leads to neuronal degeneration via a delayed cell death
process termed parthanatos (Mandir et al., 2000; David
et al., 2009; Kuzhandaivel et al., 2010). The realization
of the existence of a time lag between primary injury
and cell loss should prompt attempts to neuroprotect the
lesioned spinal cord (Baptiste and Fehlings, 2008). Inves-
tigating these issues demands animal models, though it is
difficult to relate the severity of an acute injury to later out-
come because in vivo animal studies do not readily allow
repeated time-related measurements of pathophysiologi-
cal mechanisms.
In the attempt to circumvent these difficulties, we have
developed an in vitro model of SCI based on transient
(1 h) application of the potent glutamate analogue
kainate to mimic a clinical scenario (Taccola et al.,
2008; Kuzhandaivel et al., 2011; Nasrabady et al.,
2011a) in which intensive care treatment is applied as
soon as possible to provide life support, correct metabolic
imbalance and, perhaps, restrict the early component of
excitotoxic stress (Baptiste and Fehlings, 2008; Munce
et al., 2013). One important characteristic of this model
is the possibility to analyze the functional activity of loco-
motor networks by recording their cyclic oscillatory dis-
charges (alternating between flexor and extensor motor
pools), and relate them to the topography and extent of
the induced lesion. Notwithstanding the intrinsic limita-
tions of this model (e.g. lack of blood supply), several fea-
tures appear to be reminiscent of the clinical scenario like
the limited extent of cell damage which primarily concerns
neurons (rather than glia), and motoneurons in particular
that are very vulnerable to this type of injury. Furthermore,
http://dx.doi.org/10.1016/j.neuroscience.2014.11.023
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there is very high sensitivity of locomotor networks to
damage as their electrical activity is suppressed even
when substantial cell numbers remain apparently
unscathed. These properties may render this model as
a simple predictive tool for further testing the in vivo
effectiveness of novel devices (Nistri, 2012). Our former
studies of SCI model neuroprotection have so far
obtained limited success (Nasrabady et al., 2011a,
2012) in line with disappointing clinical data (Baptiste
and Fehlings, 2008) and should stimulate further work in
this field.
The present investigation explored the usefulness of a
volatile general anesthetic like methoxyflurane as a
protective agent against experimental SCI. Volatile
anesthetics are known to be neuroprotective against
excitotoxicity in the brain (Popovic et al., 2000; Kudo
et al., 2001; Ren et al., 2014) and spinal cord (Nout
et al., 2012) although no data are currently available for
their efficacy to preserve locomotor function. Methoxyflu-
rane is a convenient drug for such studies because of its
physical properties (Andersen and Andersen, 1961; Seto
et al., 1992) and its pharmacological activity on synaptic
and firing properties has been previously reported (De
Jong et al., 1968; Richens, 1969). Hence, we tested the
ability of methoxyflurane to contrast the histological and
functional damage evoked by kainate. We employed
two protocols of administration, namely the anesthetic
was started after the application of kainate, or applied
together with kainate as a test for proof of principle for
the effectiveness of this treatment.
EXPERIMENTAL PROCEDURES
Spinal cord preparations
Thoraco-lumbar spinal cord preparations were isolated
from urethane anesthetized (0.2 ml of i.p. of a 10%, w/v
solution) neonatal Wistar rats of 0–2 day postnatal age
according to the guidelines of NIH and with the approval
of the local ethical committee. The experimental set up
was as described previously (Taccola and Nistri,
2006a). The isolated spinal cords were superfused with
Kreb’s solution (in mM: 113 NaCl, 4.5 KCl, 1 MgCl27H2O,
2 CaCl2, 1 NaH2PO4, 25 NaHCO3, 11 glucose, gassed
with 95% O2, 5% CO2, pH 7.4 at room temperature at rate
of 7.5 mL/min). In accordance with the three Rs objective,
all efforts were made to minimize the number of animals
used for the experiments and their suffering. The experi-
ments were performed in accordance with the ethical
guidelines for the care and use of laboratory animals of
National Institutes of Health (NIH) and the Italian act
D. L. 27/1/92 n. 116 (implementing the European
Community directives n. 86/609 and 93/88). All experi-
mental protocols were approved by the ethical committee
of the International School for Advanced Studies.
Electrophysiological recordings
Spinal reflexes and motoneuron field potential (FP).
Dorsal root-ventral root potentials (DR-VRPs) were
evoked by stimulating a single dorsal root (DR) through
a suction electrode with 0.5–10 V stimuli
(0.1–0.2 ms duration) and recorded from the homolateral
ventral root (VR) by using glass suction electrodes
(Taccola and Nistri, 2006a) filled with Kreb’s solution as
previously reported (Ostroumov et al., 2011). Usually five
synaptic responses were averaged for further analysis.
Recent investigations have demonstrated that spinal
motoneurons are most vulnerable to excitotoxicity
(Mazzoneet al., 2010) andsensitive tomembranepotential
changes evoked by gas anesthetics (Marinc et al., 2012).
Thus, tomonitor their functional responsesafter excitotoxic
stimulation and methoxyflurane application, motoneuron
field potentials (FP) due to synchronous motoneuron firing
(Fulton andWalton, 1986) were recorded with an extracel-
lular pipette located in the lumbar ventral horn region of
sagitally hemisected (24 h after dissection) spinal cords
continuously superfused with Kreb’s solution (Ostroumov
et al., 2011). Lumbar motoneurons were approached
blindly through the medial cut surface of spinal cords and
identified (in L3–L5 segments) on the basis of their anti-
dromic response to stimulation (2 Hz) of the corresponding
VR. After establishing the stimulus threshold value by
Fig. 1. Changes in DR-VRP amplitude after methoxyflurane treatments in vitro. (A) DR-VRP amplitude vs time following application of various
concentrations of methoxyflurane. Strong DR-VRP reduction appeared with concentration larger than 1 mM and became very strong at 4.5–6 mM
with recovery on washout. Data are from three experiments for each anesthetic concentration. (B) Acute effect of methoxyflurane (MF; 4.5 mM)
applied for 1 h at 3.5 mM or 4.5 mM concentration (n= 3 for both): complete depression of polysynaptic reflex response was apparent with gradual
recovery. Data are represented as mean ± SEM.
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straddling the pulse intensity, data were normally collected
using as standard stimulus strength a pulse of 5 V (0.1 ms).
For analysis, an average of at least 10 sweepswasused for
each FP recording. Responses were acquired and ana-
lyzed with pClamp software (version 9.2; Molecular
Devices, Sunnyvale, CA, USA).
Fictive locomotion (FL) recording.
Extracellular recordings were obtained from left L2 VR
(flexor motor signals), left and right L5 VRs (extensor
motor signals; Taccola and Nistri, 2006b) in DC-coupled
mode. To elicit FL via DR stimulation, electrical stimuli
were applied to a single ipsilateral homosegmental DR
with a train (30 stimuli at 2 Hz) of pulses (0.1 ms duration).
Typical fictive locomotor cycles emerged on top of the
cumulative depolarization induced by stimulation strength
P2 threshold (threshold taken as the minimum intensity
to elicit a detectable response in the homolateral VR;
Taccola et al., 2004; Nasrabady et al., 2011a,b). Chemi-
cally induced FL was elicited by co-application of
N-methyl-D-aspartate (NMDA; 2.5–4 lM) (Tocris Biosci-
ence, Bristol, UK) and 5-hydroxytryptamine (5-HT;
10 lM) (Sigma, Milan, Italy) (Kiehn and Kjaerulff, 1998;
Taccola et al., 2004; Nasrabady et al., 2011a,b). Continu-
ous generation of at least 20 cycles alternating between
homosegmental and left–rightP 3 L VRs was set as cri-
terion for the presence of FL. These rhythmic discharges
were analyzed for their period value (time between the
onset of two cycles of oscillatory activity), coefficient of
variation (CV), and amplitude using at least 20 continuous
oscillatory cycles.
Experimental lesion and neuron-protection protocols
The excitotoxic insult mimicking spinal lesion relies on the
in vitro application of kainate (Taccola et al., 2008) for 1 h
in standard Krebs’s solution. Kainate was applied at the
threshold concentration of 50 lM which is known to abol-
ish locomotor network activity (Mazzone et al., 2010;
Nasrabady et al., 2011b).
Along with the excitotoxic lesion by kainate, we applied
three protocols for neuroprotection by using the volatile
anesthetic agent methoxyflurane (Medical development
international Ltd., ABN 14106340667, Victoria, 3171,
Australia). Methoxyflurane was applied through perfusion
along with Kreb’s solution in an airtight container at room
temperature (20 °C). The drug inlet tube was positioned
in close proximity of the spinal cord preparation to allow
changing the bath solution in about 1 min. It is
noteworthy that, among the series of halogenated
volatile anesthetics, methoxyflurane shows good water
solubility and stability (Eger and Eger, 1985; Seto et al.,
1992), and it has high affinity for lipids (Elliott et al.,
1992; Soares et al., 2012). Before application, vigorous
mixing for at least 3 min was performed to ensure its full
solubility. Various concentrations (0.5–6 mM) were tested
for the acute effect of methoxyflurane on the amplitude of
DR-VRPs as exemplified in Fig. 1A for 10 min application
and Fig. 1B for 60 min application of the anesthetic. Thus,
the concentration of 4.5 mM was chosen as it fully
depressed the DR-VRPs in a reversible fashion (even
after 60 min application) and accorded with previous find-
ings (Richens, 1969). The first neuroprotection protocol
implied co-application of kainate (50 lM) with methoxyflu-
rane (4.5 mM) for 1 h. In the second protocol, kainate
(50 lM) was applied alone for first 30 min followed imme-
diately by 30 min co-application with methoxyflurane
(4.5 mM) and later by methoxyflurane (4.5 mM) alone for
30 min. The third protocol comprised 1 h application of
kainate (50 lM) alone, washout and subsequent applica-
tion of methoxyflurane (4.5 mM; 1 h) alone. All these
treatments were followed by 24 h continuous washout with
Kreb’s solution at room temperature. Electrophysiological
and immunohistochemical data were compared among
Fig. 2. Changes in DR-VRP amplitude after pharmacological treatments in vitro. DR-VRPs generated by electric stimulation (P2 threshold) in
whole spinal cord and hemisected spinal cord in sham and treated groups after 24 h in vitro. Note significant preservation of DR-VRPs after MF
co-applied with kainate (KA +MF), with 30 min delay (KA/KA +MF/MF) or kainate (60 min) followed by methoxyflurane (60 min; KA/MF).
⁄⁄⁄P 6 0.001 by one-way ANOVA on rank’s (Dunn’s test), when KA was compared to sham and all treated groups. ¤P< 0.001 between sham and
KA/MF (KA applied alone for 60 min which was followed by washout with MF alone for 60 min) for hemisected spinal cords; n= 5, 4, 7, 7, 4 for
whole SC and 7, 3, 7, 7, 4 for hemisected SC, respectively. Data are represented as mean ± SEM.
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distinct groups that included, after 24 h in vitro, sham
(untreated), methoxyflurane-treated, kainate-treated, and
kainate plus methoxyflurane-treated with concomitant or
staggered application as indicated above.
Immunofluorescence procedure
Full details of the immunohistochemical procedures have
recently been published (Cifra et al., 2012). In brief, after
electrophysiological analysis, paraformaldehyde-fixed
spinal cords were cryoprotected with 30% sucrose and
sectioned (35 lm) with a sliding microtome. Immunostain-
ing was performed on T13 to L5 segments, in accordance
with our former studies (Cifra et al., 2012; Bianchetti et al.,
2013). After incubation in blocking solution (5% donkey
goat serum, 5% bovine serum albumin, 0.3% Triton-X
100) for 3 h at room temperature, the primary antibody
for ChAT (choline acetyltransferase, goat polyclonal,
Chemicon, Millipore, AB144P, used 1:50) was incubated
at 4 °C for 2 days to identify motoneurons visualized as
large cells (soma diameter >20 lm) in the ventral horn.
For neuronal identification, the NeuN primary antibody
(mouse monoclonal, Chemicon, Millipore, MAB377, used
1:50) was added one day later. Primary antibodies were
visualized using secondary donkey anti-mouse Alexa fluor
488 or donkey anti-goat 594 antibodies (1:500, Invitrogen,
Carlsbad, CA, USA). Sections were finally stained with
40,6-diamidino-2-phenylindole (DAPI) for 20 min and ana-
lyzed as detailed below. All antibodies have been previ-
ously used and validated for immunostaining with our
preparations (Taccola et al., 2008; Cifra et al., 2012;
Bianchetti et al., 2013).
Cell death analysis
The method has been recently reported in detail
(Bianchetti et al., 2013). Briefly, using a Zeiss Axioskop2
microscope (Oberkochen, Germany) and Metavue
Table 1. Effect of treatments on VR polarization level in vitro
Experimental group VR polarization change (mV)
Mean ± SEM, n
KA (60 min) (50 lM) 2.52 ± 0.36, 4
MF (60 min) (4.5 mM) ÿ1.67 ± 0.26⁄⁄⁄, 4
KA +MF (60 min) 1.64 ± 0.26$, 5
KA (30 min)/KA +MF
(30 min)/MF (30 min)
0.76 ± 0.24⁄⁄,$, 5
KA (60 min)/MF (60 min) 0.90 ± 0.29⁄⁄,$,4
The data refer to the results obtained with the three protocols of neuroprotection
(see ‘Experimental procedures’ section). KA, kainate (50 lM); MF, methoxyflu-
rane (4.5 mM); KA + MF, coapplication for 60 min; KA/KA +MF/MF: 30 min
delayed application of MF continuing for further 30 min; KA/MF: application of MF
delayed 1 h after kainate. One-way ANOVA (Bonferroni t-test) was performed,
⁄⁄⁄P< 0.001 and ⁄⁄P< 0.01 when compared with KA alone and $P< 0.001
when compared to MF alone.
Fig. 3. Changes in antidromic field potentials (FPs) recorded from lumbar VRs. (A) Methoxyflurane (MF; 4.5 mM) reduced the maximum field
amplitude (circles) to half within 15 min from the start of its application and also raised the stimulus threshold (inverted triangles), followed by quick
recovery on washout. Error bars within data points (n= 3). (B) Examples of antidromic FPs superimposed to aid comparison. The arrows point to
the record trace where the amplitude value of the FP was recorded. See Fig. 2 legend for abbreviations of protocols. (C and D) Histograms of FP
amplitude and stimulus threshold compared among sham and treated groups after 24 h in vitro: the largest depression of motoneuron FP and
stimulus threshold was found after KA (kainate; 50 lM), an effect strongly prevented by all neuroprotective protocols (KA +MF, KA/KA +MF/MF
and KA/MF). (E) input/output curves of antidromic FPs recorded under incrementing stimulus intensity show preventive effect of MF for all stimulus
strengths. One-way ANOVA (post hoc Bonferroni t-test) was performed, ⁄⁄⁄P 6 0.001 when compared to KA. For panels C and E n= 9, 5, 7, 10, 5,
7; n= 15, 7, 14, 11, 11, 7 for stimulus threshold histograms, respectively. Data are represented as mean ± SEM.
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software (Metamorph suite supplied by Molecular
Devices, Sunnyvale, CA, USA) to acquire images, cell
counting was performed after DAPI staining or NeuN
positivity (for neurons). Data were quantified with
‘eCELLence’ software (Glance Vision Tech., Trieste,
Italy). For each histological cross section of the spinal
cord, three different areas were investigated as previously
reported in detail (Mazzone et al., 2010; Cifra et al., 2012;
Bianchetti et al., 2013): dorsal grey matter (Rexed lami-
nae I–IV), central grey matter (Rexed laminae V–VII and
X), and ventral grey matter (Rexed laminae VIII–IX). In
each area, a 460  185 lm region of interest (ROI) was
analyzed. For each experimental group, three spinal
cords were used and, for each spinal cord, three different
sections from T13 to L5 were examined. Pyknosis was
readily observed as a change in nuclear morphology
resulting from chromatin condensation. Motoneurons
were counted in the ventral horn ROI from T13 to L5.
Data analysis
Statistical analysis was done using SigmaStat 3.5 (Systat
Software, Chicago, IL, USA). The data were analyzed with
two-tailed Student’s t-test or with analysis of variance
(ANOVA; Bonferroni, Tukey, Dunn’s) as appropriate.
Respective tests are stated in figure captions along with
their P-values. The significance level was P 6 0.05. The
numerical data were expressed as mean ± SEM. For
electrophysiological experiments n refers to number of
preparations, while for immunohistochemical experiments
n indicates the number of tissue sections.
RESULTS
Effect of methoxyflurane on kainate-evoked
depression of synaptic reflexes
In the light of results illustrated in Fig. 1A, B, the present
study explored how 4.5 mM methoxyflurane (1 h) affected
the DR-VRP amplitude recorded from whole or
hemisected spinal cord preparations. Fig. 2 summarizes
data obtained with the various lesion protocols, namely
transient excitotoxic stimulation (50 lM kainate for 1 h;
KA) followed by washout for the subsequent 24 h and
retesting of DR-VRPs. This approach was also
investigated when methoxyflurane was co-applied with
kainate for 1 h (KA+MF), or co-applied in the second half
of the kainate application and followed by a further 30 min
administration (KA/KA+MF/MF), or applied for 1 h after
kainate had been administered for 1 h and then washed
out (KA/MF). Finally, data were collected also for
methoxyflurane application per se (MF). For sake of
Fig. 4. Neuroprotective effect of methoxyflurane (MF; 4.5 mM) on cumulative depolarization and fictive locomotion (FL) induced by DR electrical
stimuli after 24 h in vitro. (A) Examples of MF effects alone or applied with or after KA (50 lM): preservation of oscillations superimposed on
cumulative depolarization is observed. See Fig. 2 legend for abbreviations of protocols. (B) Histograms of cumulative depolarization amplitude that
was significantly decreased when compared to sham values after KA and preserved when MF was applied with the other protocols. (C and D) shows
the preservation of area and oscillations in all three neuroprotective (KA + MF, KA/KA+ MF/MF and KA/MF) protocols and MF alone has no toxic
effect on preparations whereas KA has decreased both values significantly. One-way ANOVA with Bonferroni t-test was performed, ⁄⁄⁄P 6 0.001
(KA compared to sham and all treated groups), ⁄⁄P= 0.01 (sham vs KA/KA +MF/MF), n= 5, 3, 3, 8, 6, 5 respectively. Data are represented as
mean ± SEM.
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comparison,wealso show results fromwhole or hemisected
spinal cord preparations because the latter was more
suitable to record motoneuron FPs in view of the ease of
electrode tracking without crossing the pial surface and
potential injury damage. Previous experiments have
indicated that the spinal network activity remains fully
viable in the rat hemisected preparation (Bracci et al.,
1996; Ostroumov et al., 2007, 2011).
While kainate alone largely depressed DR-VRPs
recorded one day later in accordance with previous data
(Mazzone et al., 2010), this effect of kainate was fully pre-
vented when methoxyflurane was co-applied even when
the anesthetic was started with a 30 min time lag or after
kainate washout, indicating effective neuroprotection of
polysynaptic transmission. In the rat spinal cord, kainate
is known to induce a large VR depolarization (Taccola
et al., 2008; Nasrabady et al., 2011b). Table 1 summarizes
the data ofVRpolarization changes recordedusing the var-
ious experimental protocols. Thus, the average VR depo-
larization recorded 60 min from the start of 50 lM kainate
application was 2.52 ± 0.36 mV (n= 4) vs pre-drug base-
line, whereas the value recorded 60 min after application of
methoxyflurane alone was ÿ1.67 ± 0.26 mV (n= 4),
demonstrating opposite effects on VR polarization. When
kainate was applied together with methoxyflurane, or the
anesthetic was applied later (30 or 60 min), a significantly
smaller amplitude of the VR depolarization was observed.
This finding shows that the spinal network depolarization
evoked by KA was largely reduced by MF.
Methoxyflurane contrasted depression of
motoneuron firing by kainate
Our former report (Mazzone et al., 2010) has indicated that
spinal motoneurons are highly vulnerable to kainate-
induced excitotoxicity and that substantial motoneuron
loss (even after moderate kainate concentrations) is a cru-
cial process to impair spinal network function. We, thus,
investigated whether methoxyflurane could protect moto-
neuron function monitored as synchronous firing of one
segmental motoneuron population in the face of kainate
challenge. First, we explored how methoxyflurane could
affect motoneuron spiking by measuring the maximum
FP amplitude and threshold recorded from lumbar VRs
(Fig. 3A). Methoxyflurane (4.5 mM) nearly halved the
response magnitude within 15 min and largely raised the
firing thresholdwith rapid recovery onwashout.When tests
were extended to preparations after 24 h in vitro from the
drug administration protocols, as exemplified in Fig. 3B
(average antidromic FPs are superimposed to aid compar-
ison), differing degrees of FP reduction were observed.
Hence, the largest depression of the motoneuron FP was
detected 24 h after kainate (50 lM) with strong prevention
when methoxyflurane was administered together with (or
staggered after) kainate. The anesthetic alone induced
insignificant decrease in the motoneuron FP. These data
arequantified inFig. 3C,D.Fig. 3Edepicts input/output plots
for antidromic FPs recorded under various protocols, indi-
cating that methoxyflurane could prevent the depressant
action by kainate regardless of the number of activated
motoneurons that varied in relation to the stimulus intensity.
Fictive locomotion protection by methoxyflurane
Former studies have indicated that even a moderate
excitotoxic lesion induces a clear dissociation between
limited histological damage and complete loss of FL
despite preservation of reflex activity (Mazzone et al.,
2010; Kuzhandaivel et al., 2011). In this scenario the
vulnerability of motoneurons is thought to play an impor-
tant role. The present study investigated whether
methoxyflurane could prevent the disappearance of
Fig. 5. Effect of methoxyflurane (MF; 4.5 mM) on fictive locomotion (FL) induced by chemical stimuli (2.5–4 lM NMDA and 10 lM 5HT) after 24 h
in vitro. VR records show alternating cyclic oscillations in control conditions, or after MF applied alone or with the excitotoxic insult (kainate (KA);
50 lM). See Fig. 2 legend for abbreviations of protocols. The higher gain inset indicates alternating cycles between lumbar VRs.
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locomotor network activity evoked by kainate. To this end,
we induced FL with either repeated DR stimuli or
co-application of NMDA and 5HT. Fig. 4A shows that
one day after 1 h application of 50 lM kainate, the ampli-
tude of cumulative depolarization was decreased and
oscillations typical of locomotor networks (Marchetti
et al., 2001) were abolished. When methoxyflurane was
co-applied with kainate, oscillations were preserved
(Fig. 4A, D) even though the cumulative depolarization
amplitude was decreased vs sham values (Fig. 4B), while
the total depolarization area was preserved (Fig. 4C).
Likewise, sustained locomotor cycle activity elicited by
NMDA and 5HT was suppressed 24 h after kainate, yet
retained when kainate had been applied together with
methoxyflurane as exemplified in Fig. 5 in which the
higher gain inset indicates alternating cycles between
lumbar VRs. Average data are summarized in Fig. 6A–C
that indicates good preservation of cycle amplitude and
period (and its CV value) by methoxyflurane,
notwithstanding kainate application.
Histological characteristics of spinal cord
preparations following excitotoxic protocols
Fig. 7A shows percent values of pyknotic nuclei (markers
of cell death) under various experimental conditions. As
reported earlier (Nasrabady et al., 2011b), pyknosis
evoked by kainate was the highest in the dorsal horn area
and was significantly prevented in all three ROIs when
this agent was applied together with methoxyflurane.
Likewise, neuronal numbers, even in the most sensitive
ROI, were fully preserved (Fig. 7B) as exemplified in
Fig. 7C in which neurons were identified with NeuN stain-
ing (green) and cell nuclei with DAPI (blue).
As motoneurons are a small population of cells in
the spinal network (Cifra et al., 2012), their lowered
number may strongly impact network activity. Analysis
of motoneuron numbers identified on the basis of their
ChAT immunoreactivity observed in sections from T13
to L5 segments shows that they were substantially
reduced 24 h after kainate application (Fig. 8A, B), a
phenomenon fully prevented by co-application of
methoxyflurane either together or at the end of kainate
administration.
DISCUSSION
The principal result of the present study is the
demonstration that the volatile anesthetic MF was
effective to protect spinal locomotor networks from
excitotoxicity. This observation included electrophy-
siological as well as histological protection that was
afforded even to motoneurons that are known to be very
vulnerable to this type of injury.
Choice of methoxyflurane as a neuroprotective agent
In vitro studies, like the present one, are best suited to
investigating drugs which can be applied via the bathing
solution (Kreb’s medium). Thus, among the wide series
of halogenated volatile anesthetics, methoxyflurane
appeared to be a convenient agent because of its
chemical and physical properties (Andersen and
Andersen, 1961; Eger and Eger, 1985; Seto et al.,
1992; Soares et al., 2012). In general, when their admin-
istration is prolonged, volatile anesthetics may produce
toxic effects including apoptosis in the nervous tissue
(Sanders et al., 2008; Zhao et al., 2011). Furthermore,
methoxyflurane administered to man can release fluoride
with toxic effects on peripheral organs like the kidney
(Kharasch et al., 1995, 2006), making this drug suitable
only for short term use. For these considerations, the
present investigation employed 1 h as the maximum dura-
tion of methoxyflurane application (either together with
kainate or delayed after the start of kainate administra-
tion). This protocol is supported by the recent finding that
Fig. 6. Chemically induced fictive locomotion (FL) in in vitro spinal
cord preparations after 24 h. See Fig. 2 legend for abbreviations of
protocols. (A–C) FL was completely absent in KA treated SC,
whereas in all the other groups cycle amplitude and period (and its
CV, coefficient of variance) were well preserved, indicating good
neuroprotection of locomotor networks. One-way ANOVA (Bonferroni
t-test) was performed, ⁄⁄⁄P 6 0.001 (KA compared to sham and all
treated groups), ⁄⁄P= 0.01, n= 6, 3, 3, 8, 6, 4 respectively. Data are
represented as mean ± SEM.
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a short application of a volatile anesthetic can be highly
neuroprotective against rat brain ischemia (Ren et al.,
2014). In accordance with these data, the present study
never observed any neurotoxic action by 1 h application
of methoxyflurane in terms of electrophysiological or
histological parameters.
The concentration of methoxyflurane (4.5 mM) for the
majority of the current tests was empirically selected on
the basis of its rapid and reversible depression of
electrophysiological responses. The anesthetic
concentration of methoxyflurane expressed as 1 MAC
(minimum alveolar concentration) in man is 0.16%
(Quastel and Saint, 1986; Elliott et al., 1992). Previous
reports indicate that clinically relevant concentrations do
not suppress neuronal activity completely (MacIver et al.,
1989; Elliott et al., 1992; Vahle-Hinz and Detsch, 2002).
In the present study the in vitro systemwas devoid of circu-
latory support and required a concentration comparable to
the human plasma free concentration of methoxyflurane
(low mM range) to provide general anesthesia (Eger and
Eger, 1985; Soares et al., 2012). It is interesting that, in
addition to its anesthetic properties, methoxyflurane is a
validated agent to produce analgesia after acute trauma
(Coffey et al., 2014).
Methoxyflurane induced neuroprotection
Former studies have shown kainate to be an effective
drug to induce delayed excitotoxicity which was the
strongest in the dorsal horn (where most neurons (Cifra
et al., 2012) and kainate-sensitive glutamate receptors
(Agrawal and Evans, 1986; Wang et al., 2005; Pinheiro
and Mulle, 2006) are found) and on motoneurons that,
24 h later, were more than halved in numbers. It is note-
worthy that the present protocols demonstrated a rela-
tively slow onset of synaptic or motoneuron depression
by methoxyflurane, and partial inhibition of the neuronal
depolarization evoked by kainate in analogy with the
recent report that a general anesthetic antagonizes
kainate-mediated depolarization in the frog spinal cord
in vitro (Dalo´ and Hackman, 2013). Thus, efficient preven-
tion of neurotoxicity could be detected even with slowly
developing pharmacological responses evoked by
methoxyflurane. This finding supported the protocol of
methoxyflurane application with a 30 or even 60 min delay
after the start of kainate administration: in either case
strong neuroprotection was always observed. Motoneu-
ron field potentials were uniformly protected (in terms of
amplitude and stimulus threshold) in line with the full pres-
ervation of the motoneuron numbers measured
immunohistochemically.
A simple interpretation of these data is that
administering methoxyflurane effectively stopped the
slow emergence of the non-apoptotic cell death process
typically triggered by excitotoxicity (Kuzhandaivel et al.,
2011) and peaking within the first 1–2 h.
The in vitro spinal cord preparation is intrinsically
unsuitable for long term investigations into the
locomotor network function because of poor survival
after 24 h. However, organotypic slice cultures of the rat
spinal cord are amenable to long term studies stretching
over a few weeks and have shown that the neuronal
damage caused by excitotoxicity is complete within the
first 24 h from the lesion (Mazzone et al., 2013).
It is useful to recall that the current data were obtained
with an in vitro preparation which, while being a useful
model for SCI preclinical studies (Kuzhandaivel et al.,
2011), clearly differs from the clinical setting of human
SCI. Nevertheless, tissue immaturity of the neonatal rat
spinal cord may impart certain properties similar to those
of the excitotoxic process of the human neonatal brain
(Hagberg, 1992) whose neurotoxicity is significantly inhib-
ited by the gas anesthetic isofurane (Burchell et al.,
2013).
Fig. 7. Histological changes in the rat spinal cord in vitro following excitotoxic protocols. See Fig. 2 legend for abbreviations of protocols.
(A) Histograms show percentage of pyknotic cells in the different grey matter ROIs (dorsal, central and ventral horn). Note statistically significant
decrease in pyknotic cell number in all ROIs from samples treated with methoxyflurane (MF; 4.5 mM) after the KA (kainate; 50 lM) insult versus KA
treated samples. (B) Decrease in dorsal horn neuronal number after KA damage, while good preservation was observed in all groups treated with
MF. Data are the average taken from nine sections from three rats. (C) Examples of dorsal horn neuronal staining from all protocols as this region is
normally showing the highest neurotoxic action by kainate. ⁄⁄⁄P 6 0.001 when data are compared with KA alone (Mann–Whitney test). Data are
represented as mean ± SEM.
276 A. Shabbir et al. / Neuroscience 285 (2015) 269–280
Preservation of locomotor network function
Previous studies have shown how fictive locomotion is
readily lost after an excitotoxic stimulation that may
leave spinal reflexes relatively preserved (Taccola et al.,
2008; Mazzone et al., 2010; Nasrabady et al., 2011b). In
particular, fictive locomotion induced by a train of DR
pulses is the most prone to neurotoxicity so as it is difficult
to protect it even with the mechanism-targeted drug
N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-(N,N-dimethyl-
amino) acetamide hydrochloride (PJ-34) (Nasrabady
et al., 2011b). It was, therefore, important to observe that,
despite some reduction in the cumulative depolarization
elicited by DR pulse trains, oscillatory VR discharges were
preserved. This observation was also supported by dem-
onstrating that chemically evoked fictive locomotion was
also preserved 24 h later when methoxyflurane had been
applied together with or after kainate. The unchanged
periodicity of the locomotor rhythm when compared to
sham preparations suggests that, within the organization
of the central pattern generator for locomotion (central pat-
tern generator (CPG); Kiehn, 2006; Brownstone and
Wilson, 2008), the ‘‘clock’’ oscillatory function (Taccola
and Nistri, 2006a; McCrea and Rybak, 2008) had been
well protected. Hence, not only motoneurons received a
beneficial treatment, but also oscillatory interneurons
and premotoneurons retained their full functional activity.
To the best of our knowledge, a relatively brief application
of methoxyflurane has so far been the most effective neu-
roprotective tool in our experimental model.
Clinical neurophysiological monitoring of SCI patients
at early time after the acute SCI have shown that irregular
electromyographic discharges can be recorded from
various leg muscles and are related to pathological
processes like spasticity (McKay et al., 2011). Although
Fig. 8. Motoneuron number change after excitotoxic KA (kainate; 50 lM) treatment in vitro. (A) Histograms show the number of motoneurons
counted in ventral ROI. See Fig. 2 legend for abbreviations of protocols. The number of motoneurons statistically decreased after KA excitotoxicity,
while it was preserved in all groups after application of MF (4.5 mM). Examples of motoneuron ChAT staining are shown in (B) from each protocol.
Data are the average taken from nine sections from three rats. One-way ANOVA (Bonferroni t-test) was used, ⁄⁄⁄P 6 0.001; ⁄P= 0.02 (sham vs
KA+ MF); ⁄P= 0.03 (MF vs KA+MF). Data are mean ± SEM.
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there is, so far, no evidence for long term expression of
real locomotion in the rat once the spinal cord has been
protected with methoxyflurane against kainate toxicity, it
seems likely that the alternating VR rhythmicity found
one day after the lesion was indeed the expression of
the locomotor CPG because similar patterns are
observed in man when there is locomotor recovery from
SCI (McKay et al., 2012).
Clarification of the mechanisms underlying this action
by methoxyflurane will require future experiments. It is
likely that neuroprotection was due to combinatorial
effects such as depression of synaptic transmission,
reduced axonal firing and decreased intrinsic neuronal
excitability as these are common actions exerted by gas
general anesthetics (De Jong et al., 1968; Collins et al.,
1995; Vahle-Hinz and Detsch, 2002). It is, however, note-
worthy that simple reduction of glutamatergic transmis-
sion and voltage-activated Na+ conductances by
riluzole (Cifra et al., 2013) is inadequate for early neuro-
protection against excitotoxicity in the rat spinal cord
(Sa´mano et al., 2012), although clinical data indicate that
twice-daily administration of riluzole for 2 weeks induces a
favourable outcome in the case of spinal cervical injury
(Grossman et al., 2014). Neuroprotective effects of riluz-
ole have also been reported for experimental ischemic
damage to the rat spinal cord (Wu et al., 2014).
It is tempting to suggest that, like related anesthetics,
methoxyflurane activated background K+ conductances
such as TASK1 (Sirois et al., 2000; Lazarenko et al.,
2010) strongly expressed in spinal motoneurons (Marinc
et al., 2012). This phenomenon would be consistent with
the detected VR hyperpolarization and is likely to con-
strain neuronal excitation and downsize related intracellu-
lar Ca2+ overload that, during excitotoxicity, develops
slowly (Szydlowska and Tymianski, 2010) to trigger the
development of cell damage in the spinal cord
(Kuzhandaivel et al., 2011). This hypothesis requires fur-
ther work especially when specific tools to activate or
block such channels become available. Future experi-
ments will also be necessary to find out if the neuroprotec-
tive action by methoxyflurane might be observed with
other commonly used anesthetics like propofol: this is
an interesting issue since it may help to clarify if spinal
network neuroprotection is a common feature of general
anesthesia or specific to the mechanism of action of
methoxyflurane. The relative contribution by propofol or
gas anesthetics to neuroprotection and the related mech-
anisms have recently been discussed (Zhou et al., 2012).
CONCLUSIONS
Present guidelines for treating acute spinal injury
recommend intensive care to correct homeostatic
imbalance, and to maintain life supporting functions
(Donovan, 1994; Fehlings et al., 2010). Early neurosurgical
intervention is also proposed to stabilize the lesion and to
relieve tissue compression. SCI patients subjected to early
neurosurgical intervention are reported to have a better
outcome and the same is proposed for preclinical animal
studies (Cadotte and Fehlings, 2011; Furlan et al., 2011,
2013). It is interesting that complex neurosurgery requires
general anesthesia, a procedure probably contributing to
damage limitation if applied as soon as possible. We sug-
gest that the present study is the first one to validate, under
strictly controlled experimental conditions, the usefulness
of a volatile anesthetic to protect spinal neurons and to
ensure that spinal locomotor network function remains
intact despite a potent neurotoxic challenge.
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Abstract 
 
Acute spinal cord injury is often anatomically incomplete, yet it produces paralysis with 
uncertain outcome for gait recovery despite early intensive care. In an in vitro model of 
the rat spinal cord in which injury was mimicked with moderate excitotoxic insult, we 
have observed how this paradigm readily suppressed locomotor network activity together 
with motoneuron death, arising slowly via a parthanatos-like mechanism and always 
limited in number. We wondered whether survival of motoneurons was related to their 
expression of HSP70, a cytosolic neuroprotective protein binding and sequestering 
metabolic distress-generated proteins. In the present experiments excitotoxicity evoked 
by kainate (1 h application) induced delayed (24 h), moderate loss of motoneurons that 
became pyknotic with nuclear expression of the apoptosis inducing factor (AIF), a known 
biomarker of cell death. Surviving cells showed strong expression of HSP70 with no 
nuclear AIF. The HSP70 pharmacological inhibitor VER155008 per se induced 
neurotoxicity comparable to the action of kainate in extent and AIF nuclear translocation. 
Electrophysiological recording indicated depression of motoneuron field potential with 
strongly decreased excitability and impaired synaptic transmission following kainate or 
the HSP70 blocker. Their combined application elicited more intense neurotoxicity. 
Interestingly, motoneurons in the spinal cord (24 h in vitro) showed large expression of 
HSP70 in comparison with freshly dissected tissue, suggesting that HSP70 upregulation 
was critical for survival in vitro. Our data indicate that HSP70 was one important 
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contributor to motoneuron survival from acute injury, outlining a potential future strategy 
to neuroprotect these cells by enhancing the activity of this protein. 
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Heat shock proteins; parthanatos; excitotoxicity; AIF; spinal networks 
 
Abbreviations 
KA, kainic acid (kainate); HSP70, heat shock protein 70; VER155008, 5'-O-[(4-
cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl) methyl]amino]-adenosine; AIF, apoptosis 
inducing factor; DR, dorsal root; VR, ventral root; DR-VRPs, dorsal root ventral root 
potentials; FP, field potential; ChAT, choline acetyltransferase; DAPI, 4',6-diamidino-2-
phenylindole; AU, arbitrary unit; NADH, nicotinamide adenine dinucleotide; ATP, 
adenosine triphosphate; DMSO, dimethyl sulfoxide. 
 
4 
 
Introduction 
 Excitotoxicity is one of the hallmarks of acute spinal cord injury (SCI) and develops 
rapidly1 because of increased levels of extracellular glutamate.2,3 We have recently set up 
an in vitro model of SCI caused by the glutamate analogue kainate4–6 and observed that 
the extent of neuronal damage is typically self-limited in close analogy to most clinical 
cases where the primary lesion is often anatomically incomplete.7–9 Among spinal 
neurons, motoneurons are highly vulnerable to excitotoxicity that triggers a non-apoptotic 
cell death mechanism (parthanatos2,10,11). It is, however, noteworthy that a substantial 
number of motoneurons survive. We enquired what mechanisms might be responsible for 
tilting the fine balance between cell survival and death, and focused our study on Heat-
Shock Protein 70 (HSP70) that has been reported to block both apoptosis and parthanatos 
by binding to protease activating factor-1 (Apaf-1) thereby preventing the constitution of 
the apoptosome, or by binding to apoptosis inducing factor (AIF), preventing the AIF-
mediated chromatin condensation.12–15 
HSP70 is an ATP-dependent molecular chaperone that, under normal conditions, assists 
the folding of newly synthesized polypeptides, the assembly of multi-protein complexes, 
and the transport of proteins across cellular membranes.16,17 Under various stress 
conditions, the synthesis of HSP70 enhances the ability of cells to cope with increased 
concentrations of unfolded or denatured proteins.18 Neurons are particularly vulnerable to 
protein misfolding and to intracellular accumulation of insoluble protein aggregates since 
they cannot dilute their level by cell division.16 The increased expression of HSP70 has 
neuroprotective effects in various animal models of neurodegenerative diseases19 and this 
effect is dependent on its ability to bind AIF and to inhibit programmed cell death.20,21 
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Spinal motoneurons show high levels of HSP70 in various neurodegerative disease 
models19 and after ischemia of the rat spinal cord.22,23 
The aim of present study was to investigate the spinal cell expression of HSP70 following 
kainate-mediated excitotoxicity and after pharmacological block of HSP70 to unveil its 
potential role in preventing cell death in rat spinal cord in vitro and in preserving 
electrophysiological activity. To this end, we used the HSP70 inhibitor VER155008 ( 5'-
O-[(4-cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl) methyl]amino]-adenosine)24 that 
was initially introduced as a sensitizing agent to chemotherapy against cancer cells 
relying on HSP70 for their survival.25–27 VER15508 is known to antagonize the 
neuroprotective action of HSP70 after mild traumatic brain injury.28  
 
Results 
Excitotoxicity-evoked cell death of motoneurons 
Previous reports have shown that transient application of kainate (≥50 µM concentration) 
induces delayed cell death of spinal neurons, especially of motoneurons even though a 
significant number of them survives.2,4 In the present study, we first validated the extent 
of motoneuron death observed 24 h after the application (1 h) of 50 or 100 µM kainate 
(as exemplified in Figure 1a and b): the number of large ventral horn cells 
immunopositive to ChAT (thereby identified as motoneurons) was approximately 2/3rd of 
the value in sham preparations kept for 24 h in vitro. In keeping with previous 
observations, the global number of dead motoneurons was not dependent on the kainate 
concentration once the neurotoxic threshold had been passed.4 A comparable degree of 
motoneuron loss was obtained when we applied for 24 h VER155008 (50 µM; see 
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supplemental Figure S1 for biological tests to validate this concentration). This 
observation suggested that effective HSP70 activity was important to ensure survival in 
in vitro conditions. Thus, it seemed interesting to explore if HSP70 played a major role in 
survival against excitotoxicity. 
 
HSP70 expression in control or excitotoxic conditions 
We, therefore, investigated motoneuron immunoreactivity for HSP70 that might be a 
mechanism  for neuroprotection,29,30 and for AIF taken as an  index of cell death.2,31 
Figure 2a shows examples of double immunoreactivity of motoneurons (24 h in vitro) 
and expressing HSP70 (green), and/or AIF (red), while cell nuclei were visualized with 
DAPI (blue). In sham conditions (24 h in vitro), most motoneurons were immunopositive 
for HSP70 and negative for AIF (Figure 2a1). Following 50 µM kainate application, 
motoneurons with AIF positivity as well as motoneurons expressing HSP70 were clearly 
visible 24 h later (Figure 2a2); a group co-expressing HSP70 and cytoplasmic AIF was 
also present. After 100 µM kainate application, the AIF expression was stronger and 
fewer motoneurons were HSP70 positive (Figure 2a3). Clear AIF immunoreactivity was 
also observed 24 h following the application of 50 µM VER155008 with a few 
motoneurons stained for both AIF and HSP70 (Figure 2a4). This observation is consistent 
with the reportedly distinct sites for VER155008 and AIF binding on HSP70.12,13,15,32 
The histograms of Figure 2b quantify the percent value of motoneurons (24 h in vitro) 
expressing nuclear AIF under the various experimental protocols. The highest value was 
observed following 100 µM kainate application, whereas sham preparations were 
essentially negative.  
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We next enquired how HSP70 was expressed in single motoneurons after administration 
of kainate or VER155008.  Figure 2c shows the average fluorescence intensity (AU) for 
single cell HSP70 expression. Twentyfour h after 50 or 100 µM kainate, the signal 
intensity distinguished two motoneuron groups. One showing HSP70 positivity (with no 
AIF nuclear expression) observed in sham preparations as well as in the majority of 
kainate or VER155008 treated spinal cords (see shaded bars). Conversely, the second 
group (absent in sham preparations) showed weaker HSP70 positivity (together with AIF 
nuclear translocation; open bars) in kainate or VER155008 treated spinal cords.  
 
Contrasting expression of AIF and HSP70 in motoneurons 
To further analyze the distribution of these two markers within single motoneurons, we 
used line scan confocal microscopy of cells in sham conditions or after 50 µM kainate 
(Figure 3). In this example from a sham preparation, the z-stack analysis was run at the 
site (pink circle) of crossing of the two pink lines to generate stack images as indicated at 
the bottom and right margin of Figure 3a. Figure 3b shows the motoneuron sample cell 
with DAPI-stained nucleus and poor AIF expression used for the line scan (yellow) 
across its soma. The graphs of Figure 3b1 show the distribution between cytoplasmic and 
nuclear compartment of DAPI (blue), AIF (red) and HSP70 (green). It is noteworthy that 
the AIF signal was very low throughout the line scan, while HSP70 was found 
predominantly outside the nucleus. Figure 3c shows that, on the contrary, following 50 
µM kainate treatment (1 h), two patterns of AIF expression were detected. In the cell 
labeled d1 in Figure 3d, AIF was clearly expressed in the cytoplasm with a signal spike 
just appearing in the juxta-membrane region of the nucleus, while HSP70 was uniformly 
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expressed at low level. The cell labeled as d2 (Figure 3d) showed strong AIF expression 
in all three compartment and poor HSP70 expression. In Figure 3d1-d2, both cells 
displayed, after kainate treatment, strong signal for DAPI (blue line) perhaps indicative of 
developing chromatin condensation concurrent with cell death, which is a hallmark of 
kainate-evoked excitotoxicity.33,34  These data suggest that AIF nuclear translocation was 
associated with poor HSP70 expression. 
 
Functional changes in motoneuron activity after kainate application and HSP70 
inhibition 
Previous studies have shown irreversible electrophysiological deficit of motoneurons 
following excitotoxicity.4,35 In the present report, we first investigated whether the 
damage evoked by 50 or 100 µM kainate was intensified by the application of 
VER155008 (50 µM). To isolate motoneuron electrical activity, we recorded the 
motoneuron field potential (FP) evoked by antidromic stimulation of a single VR as 
exemplified in Figure 4a. This response represents the synchronous spike generation by 
the motoneurons contained in the lumbar segment of the stimulated VR. Kainate or 
VER155008 similarly depressed the field potential, a phenomenon synergized when the 
two drugs were sequentially applied (1 plus 24 h). Not only the amplitude but also the 
excitability of motoneurons was significantly depressed (Figure 4b and c). In particular, it 
was necessary to treble the stimulus strength to evoke the field potential after kainate plus 
VER155008 application (Figure 4c and d). The depression of field amplitude was 
uniformly observed for various stimulus intensities suggesting that functionally distinct 
classes of motoneuron with differential excitability were all similarly depressed (Figure 
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4d). Qualitatively similar data were obtained with 100 µM kainate, although the field 
amplitude depression was larger and the effect of combining kainate with VER155008 
even more depressant (Figure 4a-d). 
We next enquired whether a concentration of kainate (10 µM), which is sub-threshold for 
excitotoxicity,4 could synergize with the administration of VER155008 to damage 
motoneurons. Figure 5a-d shows that, while the functional depression of the field 
potential by 10 µM kainate was modest, subsequent application of VER155008 elicited a 
strong decrease in field amplitude and stimulus threshold, clearly larger than that 
produced by VER155008 alone. 
We also explored whether synaptic transmission which is known to be impaired after 
kainate application33 was depressed by VER155008. Table 1 summarizes the data 
pertaining to polysynaptic reflex amplitude (DR-VRP) induced by single DR stimulation 
applied to the same lumbar segment from which the field potential was recorded. Thus, 
kainate had minimal effect at 10 µM, and a strong reduction at 50-100 µM. VER155008 
alone halved the reflex amplitude and synergized the depression evoked by kainate. It is 
noteworthy that VER155008 applied after 100 µM kainate led to almost complete 
disappearance of reflex activity, indicating extensive functional damage to the spinal 
networks beyond the motoneuron neurotoxicity. 
These data indicated that efficient HSP70 activity was probably important to contrast the 
excitotoxic damage elicited by kainate, and that it was also important for the survival of 
sham preparation for 24 h in vitro, in view of the deleterious effects produced by 
VER155008 per se. This latter issue was explored by comparing HSP70 expression in 
intact spinal cord tissue fixed immediately after dissection versus preparations kept in 
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vitro for 24 h. Figure 6a shows that, in a freshly fixed preparation, immunohistochemical 
expression of HSP70 in motoneurons was rather low by comparison with the one seen 
after 24 h in vitro. Figure 6b indicates that the HSP70 signal was significantly stronger 24 
h in vitro versus freshly fixed preparations.    
 
Discussion 
The principal finding of the present study is that, in an excitotoxicity model of SCI in 
vitro, strong expression of HSP70 was an important contributor to limit motoneuron cell 
death. When HSP70 was pharmacologically inhibited, a significantly larger histological 
and functional damage emerged. These results suggest that, in future, exploiting the 
neuroprotective properties of HSP70 might be a helpful strategy to improve motoneuron 
survival after acute SCI. 
 
The in vitro model of SCI 
Our previous studies have indicated that the neonatal rat spinal cord is an advantageous 
model to investigate basic mechanisms of cell death, especially those concerning the 
secondary lesion that amplify the severity of the initial insult.4,5,33 The limited degree of 
tissue damage is not directly related to the electrophysiological dysfunction because the 
locomotor circuitry is highly sensitive to these protocols with ensuing arrest of its 
activity. This preparation is, of course, immature, yet it recapitulates most of the 
characteristics of the in vivo SCI including the delayed onset of secondary damage, the 
incomplete nature of the histological loss, and the principal cell death mechanisms 
(parthanatos) also detected in vivo.36,37 It is also worth noting that prenatal and neonatal 
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SCI is not uncommon in humans,38–40 thereby making the present model relevant also to 
the understanding of neonatal SCI pathophysiology.  
In vitro and clinical cases of acute SCI are characterized by the gradual onset of 
secondary damage, implying that there is an ongoing contrast between injury-progression 
mechanisms and intrinsic neuroprotective processes. In the current study, we focused on 
the role of  HSP70 because its expression starts to rise after injury with a minimum delay 
of 30 min, and it reaches a maximum at 24 h in close time correlation with our 
experimental protocols.22,23,25 
 
HSP70 as a gatekeeper of motoneuron survival pathways 
Previous reports have shown that, after excitotoxic injury, spinal motoneurons die mainly 
through a process of programed cell death termed parthanatos, although a substantial 
number of these cells can survive the insult.2 The present study supports the notion that 
their survival is in relation to HSP70 expression whereby high levels of HSP70 protect 
motoneurons from parthanatos by preventing nuclear translocation of AIF. 
Programmed cell death pathways such as apoptosis or parthanatos are major 
physiological process responsible for the demise of damaged cells and are involved in the 
pathophysiology of SCI.2,5,35,41–44 One critical step in the parthanatos cell death process 
consists in the permeabilization of mitochondrial membranes, leading to the release of 
proteins such as AIF10 that is a flavin adenine dinucleotide-containing, NADH-dependent 
oxidoreductase suggested to play a crucial role in the maintenance of mitochondrial 
morphology and energy metabolism.21 Following insult, AIF undergoes proteolysis and 
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translocates to the nucleus, where it triggers chromatin condensation and large-scale 
DNA degradation in a caspase-independent manner.16,21  
In the presence of high level of cytoplasmic HSP70, released AIF is bound and 
sequestered by this protein, thereby reducing its ability to migrate to the nucleus with 
irreparable cell damage.12,14 It is worth noting that the pharmacological inhibitor of 
HSP70, VER155008, binds to a distinct site that corresponds to the protein activation 
domain by ATP.32 
Our data showed that, in sham conditions, the majority of motoneurons were moderately 
immuno-positive for HSP70 and negative for nuclear AIF. Indeed, maintenance of the 
spinal cord in vitro was associated with a clear rise in HSP70 expression that was almost 
absent in freshly-dissected preparations. This observation suggests that the in vitro 
condition caused a certain stress for motoneurons probably compensated at least in part 
by HSP70 expression. With an excitotoxic stimulus, metabolic distress is expected to be 
enhanced so that HSP70 expression may become an even more important player in 
contrasting cell damage (via AIF release). Our confocal analysis confirmed that 24 h after 
kainate, motoneurons with strong nuclear AIF immunostaining lacked expression of 
HSP70, whereas motoneurons with strong cytoplasmic expression of HSP70 did not 
show nuclear AIF. With a larger kainate concentration, the number of motoneurons with 
AIF translocation was increased, together with the smaller number of motoneurons 
expressing a significant HSP70.  
We currently do not know the precise mechanisms that allowed certain motoneurons to 
survive excitotoxicity, yet we noted that those that did, could express higher level of 
HSP70. This result was further supported by the observation that inhibiting HSP70 was 
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per se sufficient to evoke as much damage as kainate, and that the combined application 
of kainate and VER155008 was the most severe insult for motoneuron firing. 
Nevertheless, because a number of motoneurons survived in vitro after VER155008 
administration, we suspect that cell survival processes additional to HSP70 became 
important to ensure cell viability. Future studies are necessary for their identification. 
 
Histological survival and electrophysiological activity   
Even if, 24 h after kainate application, the loss of the motoneuron population was about 
1/3rd, it is possible that further delayed neurotoxicity might emerge later (beyond the 
survival of the in vitro preparation). This hypothesis might be applicable to those 
motoneurons already expressing AIF (24 h) prior to pyknosis and perhaps already 
showing functional deficit. This view is consistent with the observation of the 
discrepancy between histological loss (limited) and electrophysiological deficit (very 
strong) at 24 h. By recording directly the motoneuron field potential, we could find an 
intense reduction in the response amplitude (implying a smaller number of electrically 
excitable cells) with broadening of the field (indicative of scattered cell firing), plus 
clearly diminished excitability that required much stronger electrical pulses to elicit 
motoneuron firing (suggesting alterations in the motoneuron intrinsic properties). The 
latter finding was obtained after kainate or VER155008 application or their combined 
administration: hence, even surviving motoneurons likely suffered from a functional 
deficit. Likewise, premotoneuron networks were also largely affected by such treatments 
with widespread depression of polysynaptic reflexes. It is important to note that shortly 
after an acute SCI, network excitability is drastically depressed in man, a condition 
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known as “spinal shock” from which recovery is uncertain.45 This situation could be 
mimicked in our in vitro model, indicating that histology and electrophysiology did not 
go in parallel as indicators of spinal damage. Because the inhibitor of HSP70 was so 
effective in depressing synaptic transmission and antidromic motoneuron firing, it is 
tempting to speculate that ongoing network activity in vitro demands strong expression 
and function of HSP70. In conclusion, the present data suggest that motoneuron survival 
is supported by their HSP70 expression in a pathophysiological model of SCI, and that 
HSP70 is even an important contributor to ensure full motoneuron functionality of in 
vitro preparations. 
 
Material & Methods 
Animal care 
In accordance with the three Rs objective, all efforts were made to minimize the number 
of animals used for the experiments and their suffering. The experiments were performed 
in accordance with the ethical guidelines for the care and use of laboratory animals of 
National Institutes of Health (NIH) guidelines and the Italian act D. L. 27/1/92 n. 116 
(implementing the European Community directives n.86/609 and 93/88). All 
experimental protocols were approved by the ethical committee of the International 
School for Advanced Studies. 
 
Spinal cord preparations 
As reported earlier,6 neonatal Wistar rats (0-2 days) were used to prepare thoraco-lumber 
spinal cord preparations removed under  anesthesia with urethane (i.p. 0.2 ml; 10% w/v 
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solution). Kreb’s solution (in mM: 113 NaCl, 4.5 KCl, 1 MgCl27H2O, 2 CaCl2, 1 
NaH2PO4, 25 NaHCO3, 11 glucose, gassed with 95% O2, 5% CO2, pH 7.4 at room 
temperature) was used to superfuse (7.5mL/min) isolated spinal cords subsequently 
maintained in vitro for up to 24 h. 
 
Electrophysiological recordings  
One lumbar dorsal root (DR) was stimulated (0.5-10 V stimuli of 0.1 – 0.2 ms duration) 
through a suction electrode to evoke dorsal root-ventral root potentials (DR-VRPs) which 
were recorded from the homolateral ventral root (VR) by using a glass suction electrode6 
filled with Kreb’s solution. Analysis was done by averaging 5 responses at 30-60 s 
interval. Field potentials (FPs) due to synchronous firing of motoneurons46 were recorded 
with an extracellular glass pipette in the lumbar ventral horn region after 24 h in vitro.47 
After the stimulus threshold values were established, responses were collected at varying 
stimulus strength (ranging from 3 to 9 V; 0.1 ms duration). The average of 10 sweeps for 
each field potential was used for further data analysis. The data were acquired and 
analyzed with pClamp software (version 9.2; Molecular Devices, Sunnyvale, CA, USA). 
 
Experimental lesion and chemical treatments 
To mimic a spinal lesion,33 kainic acid (kainate; Tocris Bioscience, Bristol, UK) was used 
to produce excitotoxic injury in vitro. Kainate was applied for 1 h at the concentration of 
10, 50 or 100 µM, where 50 µM is the threshold concentration to abolish locomotor 
network activity.4,5 After 1 h treatment with kainate, preparations were kept in Kreb’s for 
24 h at room temperature and subjected to further electrophysiological and histochemical 
16 
 
analysis. The HSP70 antagonist VER155008 (Tocris Bioscience, Bristol, UK) was used 
to block the activity of HSP70 completely.26 The VER155008 concentration was selected 
on the basis of experiments described below and applied for 24 h.  
 
Functional tests for HSP70 inhibition 
Initial experiments were run to validate that the VER155008 concentration (50 µM) 
reported in the literature26,48,49 was effective to inhibit the action of HSP70 in functional 
tests using cell lines constitutively expressing HSP70.48,49 Thus, preliminary experiments 
were performed on SH-SY5Y cells and HEK 293T cells to check cell survival 24 h after 
VER155008 application. For both SH-SY5Y and HEK 293T cells, cell death was 
evaluated and quantified using Trypan Blue staining (Sigma-Aldrich, T8154) at the 
concentration of 0.4%, taking pyknosis of an index of cell death. 
On HEK 293T cells obtained from the SISSA in-house bank, we checked cell death and 
HSP70 expression following VER155008 application for 24 h. SH-SY5Y cells were 
cultured in Ham’s F12:EMEM (1:1) medium supplemented with 15% fetal bovine serum, 
1% Non Essential Amino Acids (NEAA) and antibiotics.50 HEK cells were cultured in 
Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum and 
antibiotics.51 Once confluent, the cells plated in 35 mm Petri dishes were divided into 
three experimental groups: one treated with VER155008 (50 µM) dissolved in DMSO 
(Sigma-Aldrich, D4540) and applied via the culture medium, one control group in 
standard culture medium, and one treated with DMSO alone (0.1 % v/v). After 24 h, cells 
were fixed in 4% paraformaldehyde for 20 min at room temperature followed by 
washing. SH-SY5Y cell images were acquired using a LEICA 6000 microscope in phase 
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contrast mode (x40 lens). Supplemental Figure 1a shows examples of SH-SY5Y pyknosis 
observed after VER15508 application: after 24 h the dead cells were 9 %, a value clearly 
larger than the effect due to DMSO alone. 
Immunocytochemistry was performed on HEK 293T cells: after incubation in blocking 
solution (5% normal goat serum, 5% bovine serum albumin, 0.3% Triton-X 100) for 1 h 
at room temperature, the primary antibody for HSP70 (Abcam, ab6535, 1:200) was 
incubated at 4 ºC overnight. This antibody has been previously validated for 
immunohistochemistry.52–55 The primary antibodies were visualized using secondary 
anti-mouse Alexa Fluor 488 (Invitrogen, CA, USA, 1:500). Specimens were finally 
stained with DAPI for 20 min and images were acquired using a LEICA 6000 microscope 
(x20 lens). Supplemental Figure 1b shows examples of HSP70 expression by HEK cells 
after 24 h in vitro. When cells were treated with VER155008, substantial pyknosis was 
observed together with loss of HSP70 expression. These results indicated that 
VER155008 at the concentration of 50 µM was toxic to cells via HSP70 inhibition. 
 
Immunofluorescence procedure on spinal cord preparation 
The procedure for staining and identifying motoneurons was reported earlier.42,56 Briefly, 
paraformaldehyde-fixed spinal cords were cryoprotected with 30% sucrose and sectioned 
(35 µm) with a sliding microtome. Immunostaining was performed on sections from T13-
L3 segments as they contain the locomotor central pattern generator.57 After incubation in 
blocking solution (5% donkey serum, 5% bovine serum albumin, 0.3% Triton-X 100) for 
3 h at room temperature, the primary antibody for ChAT (choline acetyltransferase, goat 
polyclonal, Chemicon, Millipore, AB144P, 1:50) was incubated at 4 °C for 2 days to 
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identify motoneurons visualized as large cells (soma diameter >20 µm) in the ventral 
horn. After incubation in blocking solution (10% goat serum, 5% bovine serum albumin, 
0.3% Triton-X 100) for 3 h at room temperature, the primary antibody for AIF (Upstate, 
Millipore, 04-430, 1:50) and for HSP70 (Abcam, ab6535, 1:200) were incubated at 4 °C 
overnight. Primary antibodies were visualized using secondary donkey anti-goat 594 
antibodies or goat anti-mouse Alexa Fluor 488 or goat anti-rabbit Alexa Fluor 594 
(1:500, Invitrogen, CA, USA). Sections were stained with DAPI for 20 min and analyzed 
as detailed below. ChAT and AIF antibodies have been previously used and validated for 
immuno-staining with our preparations.42,56 
 
Immunofluorescence data quantification 
These procedures have been described in detail earlier.42 In brief, using a Zeiss 
Axioskop2 microscope (Oberkochen, Germany) and Metavue software (Metamorph suite 
supplied by Molecular Devices, Sunnyvale, CA, USA) to acquire images, motoneuron 
numbers were counted on the basis of ChAT positivity in the T13-L5 ventral horn (Rexed 
laminae VIII–IX). For each experimental group, three spinal cords were analyzed and, for 
each spinal cord, three different sections from T13 to L5 were examined. Fluorescence 
intensity (expressed in arbitrary units; AU) was measured using constant setting and 
threshold values to allow data comparison. Data were quantified with ‘eCELLence’ 
(Glance Vision Tech., Trieste, Italy) software.  
Confocal images of single motoneurons were acquired with a LEICA microscope 
(TCSSP2), using 0.5-μm z sectioning as reported by Oh et al., (2006). After 
reconstructing the cell image, we selected a single central optical section that comprised 
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the largest nuclear staining with DAPI. Thereafter, we performed a line scan of such an 
image to verify the distribution of AIF and HSP70 immunofluorescence signals in the 
nucleus and in the cytoplasm. The number of reconstructed motoneurons showing AIF 
nuclear translocation was quantified with ImageJ (http://rsb.info.nih.gov/ij). 
 
Data analysis 
Statistical analysis was done with SigmaStat 3.5 (Systat Software, Chicago, IL, USA). 
The normality test (Anova Tukey) was performed first to distinguish parametric from 
non-parametric data that were then analyzed with either Student’s t-test or any other test 
as appropriate. The significance level was P ≤ 0.05. For electrophysiological experiments 
n refers to number of preparations, while for immunohistochemical experiments n 
indicates the number of tissue sections.   
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 Title and legends to figures 
 
Figure 1 Change in motoneuron number 24 h after excitotoxic injury by kainate (KA; 
50µM and 100 µM) and VER155008 (50 µM). (a) Example to motoneuron ChAT 
immunolabeling are shown for various experimental protocols and histogram (b) shows 
the number of motoneurons counted in ventral horn, where it is significantly higher in 
sham when compared to all other groups by Student’s t-test.  ***P ≤ 0.001 and data are 
mean ± SD (n = 9 for each group). 
 
Figure 2 Expression of AIF and HSP70 in motoneurons 24 h after experimental 
treatment. From left to right a1-4 shows example of staining for AIF (red), HSP70 
(green) and DAPI (blue) in a sham prepration, treated with 50 or 100 µM kainate or 50 
µM VER155008, respectively. (b) shows histograms of percent change in motoneuron 
number expressing nuclear AIF (nAIF) as an index of cell death after the same treatment. 
P ≤ 0.001, n=9 sections from 3 spinal cord for each group. (c) shows 
immunofluorescence signal (AU) of single motoneurons expressing HSP70 alone (shaded 
bars) or together with nuclear AIF (open bars). One way ANOVA (Bonferroni t-test) was 
performed; ***P ≤ 0.001 when sham (shaded bar) and kainate (open bar) was compared 
to all the other groups. $P ≤ 0.001 and @P ≤ 0.001 compared to kainate (KA; 50µM and 
100 µM). Data are mean ± SD (n = 9 for each group). 
 
Figure 3 Confocal analysis of DAPI, HSP70 and AIF signal in motoneurons after KA 
50µM. (a) example of confocal analysis of a single sham motoneurons. The pink lines are 
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centered on a motoneuron whose nucleus is outlined (in pink colour). This cell is then 
subjected to z-stack analysis in the z-plane (right and bottom insets). A line scan across 
this cell (as exemplified in b) yields the plots depicted in b1 in which the three markers 
are shown for the cytoplasmic and nuclear compartments. Note strong nuclear 
distribution of DAPI (blue) versus AIF and HSP70. (c) Similar analysis is used for the 
sample obtained 24 h after KA (50µM). Two cells are exemplified in d where d1 shows 
strong cytoplasmic location of AIF with low expression of HSP70 as quantified in the 
plot for d1. The cell d2 shows more homogeneous distribution of AIF across the 
cytoplasm and nucleus (with minimal HSP70 expression). Note DAPI signal colocalized 
with AIF in the nucleus. Scale bar: 30 µm.  
 
Figure 4 Effect of HSP70 antagonist (VER155008; 50µM) and kainate (KA; 50-100µM) 
on motoneuron field potential (FP) evoked by antidromic activation of a single VR. (a) 
Representative FP traces of experimental groups superimposed for comparison purpose. 
Note the significant reduction in field amplitude in the histograms (b) in comparison with 
sham (n = 10, 9, 9, 5, 10, 5 spinal cords, respectively). The histograms (c) show 
significant increase in stimulus threshold when VER155008 was applied for 24 h after 
KA (50 µM and 100 µM) 1 h application. (d) input/output curves of antidromic field 
potentials for various stimulus intensities; n=14, 12, 13, 5, 11, 5 spinal cords, respectively 
for data in c and d. One way ANOVA (Bonferroni t-test) was performed; **P ≤ 0.01, 
***P ≤ 0.001. Data are mean ± SME. 
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Figure 5 Effect of HSP70 antagonist (VER155008; 50µM) and a concentration of 
kainate (KA; 10 µM) subthreshold for neurotoxicity on FP evoked by antidromic 
activation of a single VR. (a) represents the average FPs following various treatments as 
indicated. In the histograms (b) the amplitude of FPs was significantly decreased when 
kainate was applied with VER155008, whereas kainate alone has no significant effect on 
FP (n=8, 7, 9, 7). Stimulus threshold for FP (c) was significantly increased among all 
experimental groups. (d) shows field amplitude for incrementing stimulus strength; n=14, 
10, 10, 8. One way ANOVA (Bonferroni t-test) was performed; *P = 0.03, **P ≤ 0.01, 
***P ≤ 0.001. Data are mean ± SME. 
 
Figure 6 Expression of HSP70 in freshly fixed (FF) vs sham (24 h) preparations. (a) 
expression of HSP70 was relatively high in sham spinal cord when compared to FF.  
Histograms (b) show fluorescence intensity (AU) significantly lower in FF with ***P ≤ 
0.001 when Student’s t-test was performed. Data are mean ± SD.    
 
Supplemental Figure S1 Validation of the VER155008 concentration (50 µM) as 
inhibitor of HSP70, using cell lines constitutively expressing HSP70. (a) Examples of 
SH-SY5Y pyknosis observed after VER15508 application (phase contrast images). Cell 
death was quantified in (b) with 9 % pyknosis measured after VER155008 application for 
24 h. *P = 0.03 when Mann-Whitney test was performed, n = 4. The effect of the solvent 
DMSO was negligible. (c) DAPI and HSP70 signals in HEK cells in sham conditions 
(top row), or following VER155008 application for 24 h (bottom row). Arrows indicate 
examples of pyknotic nuclei. As shown in the histograms (d), cell death after the 
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application of VER155008 was 24 % of the total cell number, a value significantly 
different from sham or DMSO conditions. ***P ≤ 0.001, *P = 0.02 when Student’s t-test 
was performed, n = 4. Data are mean ± SD. 
 
 
 
 
31 
 
Table 1 Changes in DR-VRP amplitude in sham and pharmacologically treated spinal 
cord preparations after 24 h in vitro.  
 
Treatment Amplitude (mV) ± SEM 
Sham 0.86 ± 0.02 
VER155008 (50 µM) 0.38 ± 0.05*** 
KA (10 µM) 0.63 ± 0.09 
KA (10 µM) + VER 0.17 ± 0.04***, $ 
KA (50 µM) 0.46 ± 0.06 *** 
KA (50 µM) + VER 0.17 ± 0.02 ***, β, $, ^ 
KA (100 µM) 0.41 ± 0.02 *** 
KA (100 µM) + VER 0.08 ± 0.01 ***, β, $, ^, ¤ 
 
 
n = 7, 4, 8, 3, 7, 6, 9, and 3 spinal cords, respectively. KA; kainate. One way ANOVA 
(Bonferroni t-test) was performed; ***P ≤ 0.001 when compared to sham. βP ≤ 0.002 
when compared to VER155008 alone. $P ≤ 0.01 when compared to KA (10 µM). ^P ≤ 
0.001 when compared to KA (50 µM) and ¤P ≤ 0.001 when compared to KA (100 µM). 
Data are mean ± SEM.  
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Discussion 
 
The principal findings presented in this thesis demonstrate a few important aspects 
related to the basic mechanisms underlying the acute phase of spinal cord injury. In 
an excitotoxicity model of spinal cord injury in vitro, the volatile anesthetic 
methoxyflurane was very effective to protect spinal locomotor networks (Paper I). 
The neuroprotective mechanism against excitotoxicity, in part, relies on strong 
expression of heat shock protein 70 (HSP70) in motoneurons (Paper II). The details 
of our novel studies are reported and explained in attached papers; however, in this 
section I will briefly discuss the main findings of present thesis.  
 
1. In vitro Spinal Cord Injury (SCI) Model 
 
The current data were obtained using an in vitro model of SCI based on transient (1 h) 
application of the potent glutamate analogue kainate to mimic a clinical scenario 
(Kuzhandaivel et al., 2011; Nasrabady et al., 2011a; Taccola et al., 2008). Although 
these preparations are immature and have some limitations like tissue immaturity and 
lack of vascular supply yet they show most of the characteristics of in vivo spinal cord 
injury including the delayed onset of secondary damage, the incomplete nature of the 
histological loss, and the cell death mechanisms, in particular parthanatos (Genovese 
and Cuzzocrea, 2008; Kuzhandaivel et al., 2011; Wu et al., 2009). One important 
characteristic of this model is the possibility to analyze the functional activity of 
locomotor networks by recording their cyclic oscillatory discharges (alternating 
between flexor and extensor motor pools), and relate them to the topography and 
extent of the induced lesion. The locomotor networks are highly sensitive to damage 
as their electrical activity is suppressed even when substantial cell numbers remain 
apparently intact. It is also worth noting that prenatal and neonatal SCI is not 
uncommon in humans (Barnes et al., 2008; Fenger-Gron et al., 2008; Selvarajah et 
al., 2014), thereby making the present model relevant also to the understanding of 
neonatal SCI pathophysiology.  
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2. Methoxyflurane as Neuroprotective Agent 
 
Since general volatile anesthetics tend to exert some neuroprotective effect when used 
clinically, this notion gave rise to the idea of using this halogenated volatile anesthetic 
which can be applied through the bath solution (Kreb’s medium) in in vitro studies 
like the present one. Methoxyflurane seemed to be the valid candidate because of its 
chemical and physical properties (Andersen and Andersen, 1961; Eger and Eger, 
1985; Seto et al., 1992; Soares et al., 2012). The favorable concentration of 
methoxyflurane (4.5 mM), that can suppress synaptic transmission fully, was chosen 
after trying various concentrations between 0.5 – 6 mM. Thus, the concentration of 
methoxyflurane (4.5 mM) for the majority of the current tests was empirically 
selected on the basis of its rapid and reversible depression of electrophysiological 
responses. Methoxyflurane (4.5 mM) was applied for 1 h owing to the fact that 
prolonged administration of volatile general anesthetics may produce toxic effects 
including apoptosis of nervous tissue (Sanders et al., 2008; Zhao et al., 2011), 
whereas short application of such anesthetics can be highly neuroprotective against 
rat brain ischemia (Ren et al., 2014).  
 
2.1. Effects of Methoxyflurane on Functional Outcomes 
 
Excitotoxicity induced by kainate (50 µM for 1 h) as described in previous reports 
from our lab (Mazzone et al., 2010; Nasrabady et al., 2012; Taccola et al., 2008) 
resulted in a functional deficit. It significantly reduced the amplitude of polysynaptic 
DR-VRPs, increased the FP stimulus threshold and decreased the FP amplitude after 
24 h. In the present study, no neurotoxic action of methoxyflurane alone was 
observed after 1 h application. Methoxyflurane, when applied together with kainate 
(coapplication and 30 min delayed) or after kainate washout (1 h kainate followed by 
1 h methoxyflurane), showed very strong neuroprotection of polysynaptic 
transmission in whole and hemisected spinal cords by preventing the depressive 
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effects of kainate (50 µM) after 24 h. Kainate is known to produce large ventral root 
(VR) depolarization in rat spinal cord (Nasrabady et al., 2011b; Taccola et al., 2008), 
but when it was applied in combination with methoxyflurane (co-application, 30 min 
delay and after washout), it significantly reduced the VR depolarization amplitude, 
measured 60 min from the start of application. This relatively slow onset of synaptic 
or motoneuron depression by methoxyflurane and partial inhibition of neuronal 
depolarization evoked by kainate is in analogy with the recent studies by Daló and 
Hackman (2013) that a general anesthetic antagonizes kainate mediated 
depolarization in an in vitro model of the frog spinal cord.  
Spinal motoneurons are the most vulnerable to kainate induced excitotoxicity 
(Mazzone et al., 2010) and a substantial number of motoneurons are required for 
proper spinal network function expressed as motor output (Nistri, 2012). We, thus, 
investigated whether methoxyflurane could protect motoneuron function monitored as 
synchronous firing of motoneuron population with/after kainate. The direct 
application of methoxyflurane for only 15 min was sufficient to halve the FP 
amplitude and largely raised the firing threshold recorded from lumbar VRs, with 
rapid recovery on washout. After 24 h in vitro, when methoxyflurane had been 
applied with or after kainate, it strongly prevented the depression of motoneuron FP 
amplitude in comparison with kainate alone. Methoxyflurane also prevented the 
increase in the stimulus threshold. These findings strongly suggest that 
methoxyflurane is highly neuroprotective. A simple interpretation of these data is that 
administering methoxyflurane effectively stopped the slow emergence of the non-
apoptotic cell death process typically triggered by excitotoxicity (Kuzhandaivel et al., 
2011) and peaking within the first 1-2 h. 
 
2.2. Histological Effects of Methoxyflurane  
 
We have also conducted a detailed histological analysis on the preparations to access 
methoxyflurane effects on the neuronal population, in particular motoneurons. The 
pyknosis was significantly higher in kainate treated spinal cords as reported earlier 
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(Nasrabady et al., 2011b), but it was significantly decreased in all the methoxyflurane 
treated groups together with or after kainate. The neuronal number (identified by 
NeuN nuclear staining) was also preserved even in the most vulnerable region (dorsal 
horn). While motoneurons are just a small population of cells in the spinal network 
(Cifra et al., 2012), they are essential for motor function. Hence, when we counted 
their number after ChAT immuno-staining, they were found to be well preserved, 
therefore supporting efficient network activity in methoxyflurane treated spinal cords 
(with or after kainate).  
 
2.3. Effect of Methoxyflurane on Locomotor Network Function 
 
Kainate induced excitotoxicity was shown to abolish fictive locomotion (FL) in spinal 
cord in vitro preparations ( Nasrabady et al., 2011b; Mazzone et al., 2010; Taccola et 
al., 2008). It is important to mention that the fictive locomotion induced by the train 
of DR pulses is the most sensitive to neurotoxicity, as even a mechanism targeted 
drug like PJ34 has failed to preserve it effectively (Nasrabady et al., 2011b). After 24 
h in vitro followiing methoxyflurane applied together with or after kainate, except for 
some reduction in cumulative depolarization, the oscillatory VR discharges and total 
area of depolarization evoked by DR pulse trains were preserved. A similar result was 
seen with chemically induced FL by NMDA and 5HT. The preservation of 
periodicity of locomotor rhythms suggest that the “clock” oscillatory function 
(McCrea and Rybak, 2008; Taccola and Nistri, 2006) within the organization of the 
central pattern generator for locomotion (Brownstone and Wilson, 2008; Kiehn, 
2006) had been well protected. Thus, not only motoneurons were spared, but also 
oscillatory interneurons and premotoneurons retained their full functional activity.   
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2.4. Mechanism of Methoxyflurane Neuroprotection 
 
To better understand the mechanism underlying the neuroprotective effect of 
methoxyflurane, further experimentation is required. Nevertheless, it is feasible to 
propose that this neuroprotective effect is result of combinatorial effect of synaptic 
transmission depression, reduced motoneuronal firing and decreased intrinsic 
neuronal excitability as these are common actions of volatile general anesthetics 
(Collins et al., 1995; De Jong et al., 1968; Vahle-Hinz and Detsch, 2002). 
Impaired glutamate uptake is a major process contributing to neuronal cell death after 
excitotoxicity. The activation of metabotropic glutamate receptors are responsible for 
higher levels of extracellular glutamate and these receptors are highly expressed in rat 
spinal cord where they regulate synaptic transmission (Marchetti et al., 2003).  
General volatile anesthetics may neuroprotect by blocking the glutamate receptor 
mediated neurotoxicity in in vivo models of brain ischemia (Popovic et al., 2000). It 
has also been reported that the volatile general anesthetic isoflurane reduces the size 
of lesion when maintained for longer time periods after microinjections of NMDA or 
AMPA into the  rat cerebral cortex (Harada et al., 1999; Kimbro et al., 2000). Thus, it 
can be suggested that general volatile anesthetics like methoxyflurane may produce 
neuroprotective effects via mechanisms involving the attenuation of glutamate 
neurotoxicity by either reducing its release (or enhancing its uptake), or antagonizing 
postsynaptic glutamate receptors.  
TASK1 channels are strongly expressed in spinal motoneurons (Marinc et al., 2012). 
They can constrain neuronal excitation and downsize related intracellular Ca2+ 
overload that, during excitotoxicity, develops slowly (Szydlowska and Tymianski, 
2010) to trigger the development of cell damage in the spinal cord (Kuzhandaivel et 
al., 2011).  Methoxyflurane can also protect spinal cord by activating background K+ 
channels such as TASK1, in analogy to chemically-related anesthetics (Lazarenko et 
al., 2010; Sirois et al., 2000). This hypothesis can further be tested once highly 
selective tools to block or activate these channels will be available.  
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The spinal cord in vitro normally shows spontaneous synaptic activity mediated 
predominantly by glutamate, GABA and glycine receptors distributed within the local 
networks impinging on motoneurons. However, pharmacological block of these 
receptors (while inhibiting ongoing activity) does not hyperpolarize motoneurons 
(Bracci et al., 1997; Mazzone et al., 2010). This suggests that resting membrane 
potential is controlled by other factors like background K+ channels, particularly that 
of TASK family. Thus, if methoxyflurane had acted mainly on tramsitter-activated 
channels, motoneuron hyperpolarization would not have been observed. However, 
methoxyflurane has evoked hyperpolarization which suggests that the principal target 
of this anesthetic action is K+ channels rather than ligand gated ion channels. 
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3. Motoneurons Cell Death Pathways and Potential Intrinsic Role of HSP70 
 
Previous reports have shown that, spinal motoneurons die mainly through a process 
of programed cell death termed parthanatos (David et al. 2009; Kuzhandaivel et al. 
2011; Mandir et al. 2000) after excitotoxic injury, although a substantial number of 
these cells can survive the insult (Kuzhandaivel et al., 2011). The present study 
(Paper II) supports the notion that their survival is in relation to HSP70 expression, 
whereby high levels of HSP70 protect motoneurons from parthanatos by preventing 
nuclear translocation of AIF (Giffard and Yenari, 2004; Gurbuxani et al., 2003; 
Ravagnan et al., 2001; Ruchalski et al., 2006). Furthermore, the expression of HSP70 
starts to rise after injury with a minimum delay of 30 min, and it reaches a maximum 
at 24 h in close time correlation with our experimental protocols (Carmel et al., 2004; 
Cizkova et al., 2004; Hecker and McGarvey, 2011). 
Our data indicated that the majority of motoneurons were moderately immuno-
positive for HSP70 and negative for nuclear AIF in sham conditions after 24 h. 
Indeed, maintenance of the spinal cord in vitro was associated with a clear rise in 
HSP70 expression that was almost absent in freshly-dissected preparations. This 
observation suggests that the in vitro condition caused a certain stress for 
motoneurons probably compensated at least in part by HSP70 expression. With an 
excitotoxic stimulus, metabolic distress is expected to be enhanced so that HSP70 
expression may become an important player in contrasting cell damage (via AIF 
release). 
We studied the distribution of HSP70 and AIF in sham and kainate (50 µM) 
preparations and our confocal line scan analysis confirmed that 24 h after kainate, 
motoneurons with strong nuclear AIF immunostaining lacked expression of HSP70, 
whereas motoneurons with strong cytoplasmic expression of HSP70 did not show 
nuclear AIF. After kainate treatment, strong DAPI signal was observed in the nucleus 
of motoneurons which perhaps indicated the development of chromatin condensation 
as an index of cell death, a hallmark of kainate induced excitotoxicity (Taccola et al., 
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2008; Wang et al., 2005). With a larger kainate concentration, the number of 
motoneurons with AIF translocation was increased, together with the smaller number 
of motoneurons expressing a HSP70. These data suggested that AIF nuclear 
translocation was associated with poor HSP70 expression.  
 
3.1. Inhibition of HSP70 by VER155008 
 
VER155008 was used to block the HSP70 activity completely (Massey et al., 2010). 
The VER155008 concentration (50 µM) reported in the literature (Budina-Kolomets 
et al., 2014; Jiang et al., 2013; Massey et al., 2010) was validated on the basis of 
initial experiments performed on cell lines constitutively expressing HSP70 (Budina-
Kolomets et al., 2014; Jiang et al., 2013). SH-SY5Y cells and HEK 293T cells were 
quantified, using Trypan Blue staining, for cell death after 24 h of VER155008 
application. The cells which were treated with VER155008 showed substantial 
pyknosis together with loss of HSP70 expression in comparison with sham and 
DMSO treated cells. These data indicated that VER155008 (50 µM) was toxic to cells 
via HSP70 inhibition. For our further experiments VER155008 was used at the 
standard 50 µM concentration for 24 h in vitro. 
 
3.2. Excitotoxicity Induced Cell Death of Motoneurons 
 
In the present study, we validated the extent of motoneuron death observed 24 h after 
kainate (50 or 100 µM for 1 h) washout. The motoneurons were identified as large 
ventral horn cells to ChAT immunopositivity and were found to be significantly 
reduced in kainate treated spinal cords when compared to sham. In keeping with 
previous observations, the global number of dead motoneurons was not linearly 
dependent on the kainate concentration once the neurotoxic threshold had been 
passed (Mazzone et al., 2010). The cords treated with VER155008 only also showed 
comparable loss of motoneurons suggesting that effective HSP70 activity was 
important to ensure survival in in vitro conditions.  
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3.3. Expression of HSP70 and AIF after Excitotoxicity and VER155008 
 
Motoneurons were further investigated for their immunoreactivity to HSP70 (that 
might be a mechanism  for neuroprotection; (DeMeester et al., 2001; Welsh et al., 
1992), and for AIF expression taken as an  index of cell death (Kuzhandaivel et al., 
2011; Yu et al., 2006). In sham conditions, most motoneurons were immunopositive 
for HSP70 but not for AIF, whereas clear AIF immunoreactivity was observed after 
kainate (50 or 100 µM for 1 h) and VER155008 (50 µM) in the majority of the 
motoneurons (few motoneurons were co-stained for both AIF and HSP70). This 
observation is consistent with the reportedly distinct sites for VER155008 and AIF 
binding on HSP70 (Giffard and Yenari, 2004; Gurbuxani et al., 2003; Ruchalski et 
al., 2006; Schlecht et al., 2013). When motoneurons were quantified for AIF 
translocation into the nucleus, the highest value was observed following 100 µM 
kainate application, whereas sham preparations were essentially negative. The signal 
intensity analysis for HSP70 distinguished two motoneuron groups 24 h after kainate 
(50 or 100 µM for 1 h) and VER155008 (50 µM); one with strong HSP70 positivity 
(with no AIF nuclear expression) observed in the majority of sham preparations as 
well as in the kainate or VER155008 treated spinal cords, and another one (absent in 
sham preparations) that showed weaker HSP70 positivity (together with AIF nuclear 
translocation) in kainate or VER155008 treated spinal cords.  
 
3.4. Functional Deficit after Excitotoxicity and HSP70 Inhibition in 
Motoneurons 
 
We next investigated the effect of kainate and VER155008 on motoneuron synaptic 
transmission and their field potentials. Previous studies have shown irreversible 
electrophysiological deficit of motoneurons following excitotoxicity (Mazzone et al., 
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2010; Nasrabady et al., 2011b). In the present study, we recorded the motoneuron 
field potential (FP) evoked by antidromic stimulation of a single VR to investigate 
whether the damage evoked by 50 or 100 µM kainate was intensified by the 
application of VER155008 (50 µM). An intense reduction was observed in the 
response amplitude (implying a smaller number of electrically excitable cells) with 
broadening of the field which is indicative of scattered cell firing. The increased 
stimulus threshold also suggested alterations in the motoneuron intrinsic properties. 
Hence, our data indicated that even the surviving motoneurons suffered from a 
functional deficit. We also enquired whether a concentration of kainate (10 µM), 
which is sub-threshold for excitotoxicity (Mazzone et al., 2010), could synergize with 
the administration of VER155008 to damage motoneurons. Although, the functional 
depression of the field potential by 10 µM kainate was modest, subsequent 
application of VER155008 elicited a strong decrease in field amplitude and increase 
in stimulus threshold, clearly larger than that produced by VER155008 alone. 
Likewise, widespread depression of polysynaptic reflexes was observed in all the 
treated groups except for 10 µM kainate. This deficit was particularly strong in all the 
instances when VER155008 was co-applied with kainate, indicating extensive 
functional damage to the spinal networks beyond the motoneuron neurotoxicity. It is 
suggested that network activity in vitro demands strong expression and function of 
HSP70. 
In the present study it was evident that the electrophysiological deficit was much 
stronger than histological damage when HSP70 was inhibited. This effect might be 
somewhat similar to the condition of spinal shock (depressed network excitability) 
which is observed in humans shortly after acute spinal cord injury and is not closely 
related to the extent of lesioned tissue (Hiersemenzel et al., 2000). Although we 
currently do not know the precise mechanisms that allowed certain motoneurons to 
survive excitotoxicity, it is apparent that high levels of HSP70 were usually 
associated with survival. This result was further supported by the observation that 
inhibiting HSP70 caused as much damage as kainate alone.   
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Conclusion and Future Prospective 
 
 
The novel findings discussed in the present thesis are interesting, yet intriguing. To 
the best of our knowledge, a relatively brief application of methoxyflurane has so far 
been the most effective neuroprotective tool in our experimental model. 
Methoxyflurane has strongly protected spinal neurons as well as locomotor network 
function against a potent neurotoxic insult. Our lab’s work with riluzole has indicated 
that simple reduction of glutamatergic transmission and voltage activated Na+ 
conductances (Cifra et al., 2013)  is inadequate for early neuroprotection in the rat 
spinal cord after excitotoxicity (Sámano et al., 2012). Conversely, neuroprotective 
effects of riluzole have been reported for experimental ischemic damage to the rat 
spinal cord (Wu et al., 2014).  The shorter application time of methoxyflurane without 
any neurotoxicity is also an important result since longer exposure (5 – 6 h) to 
volatile general anesthetic can be eventually neurotoxic (Sanders et al., 2008). We 
suggest that, in addition to early neurosurgery of acute spinal cord injury, the 
neuroprotective role of volatile general anesthetics should be exploited to aim for a 
better recovery. In future more experiments will be necessary to find out if this 
neuroprotective affect is exclusive to methoxyflurane or is a common mechanism of 
action for other anesthetics like propofol.  
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In conclusion to the second part of thesis regarding HSP70 assisted neuroprotection 
mechanisms, our data suggest that motoneuron survival is supported by their HSP70 
expression in a pathophysiological model of SCI. Nevertheless, we suspect that 
additional processes for cell survival are in action to ensure cell viability owing to the 
fact that a few motoneurons still survived in vitro after strong HSP70 inhibition. 
Future studies are necessary for the identification of such unknown mechanisms. 
These findings can be further strengthened by the use of potent HSP70 enhancing 
agents like celestrol and arimoclomol. Celastrol is known to elevate the cellular 
expression of HSP70 and recently it has been shown to prevent the onset and 
progression of damage after traumatic brain injury in vivo (Eroglu et al., 2014). 
Arimoclomol is a drug going through the second phase of clinical trails for the 
treatment of amyotrophic lateral sclerosis (ALS) (Brown, 2007). The induced 
overexpression of HSP70 before ischemia in rat brain in vivo is demonstrated to be 
neuroprotective and the process is attributed to anti-apoptotic activity of HSP70 
among other mechanisms (Giffard et al., 2004).   
 
The novel findings of this thesis have translational value for the current approaches 
used to deal with spinal cord injury mechanism and its neuroprotection. It is clear that 
our results will need direct validation with in vivo injury models as well as human 
clinical cases. Nonetheless, we suggest that early intervention against the secondary 
damage of spinal cord injury has now more exciting prospects for improving the 
functional outcome.  
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5HT 5-hydroxytryptamine 
AIF apoptosis inducing factor 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
Apaf-1 apoptotic protease activating factor-1 
APV 2-amino-5-phosphonopentanoic acid 
ASIA American Spinal Injury Association 
ATP adenosine triphosphate 
AU arbitrary unit 
BDNF brain-derived neurotrophic factor 
BDNF Brain-derived neurotrophic factor 
ChAT choline acetyltransferase 
CINs commissural interneurons 
CNQX 7-nitro-2,3-dioxo-1,4- dihydroquinoxaline-6-carbonitrile 
CNS central nervous system 
CPG central pattern generator 
CV coefficient of variance 
DAPI 4',6-diamidino-2-phenylindole 
DMSO dimethyl sulfoxide 
DR dorsal root 
DR-VRPs dorsal root ventral root potentials 
FGF fibroblast growth factor 
FL fictive locomotion 
FP field potential 
GABA γ-Aminobutyric acid 
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Gata2 and 3 GATA binding protein 2 and 3 
GDNF Glial cell-derived neurotrophic factor 
GluR1-4 glutamate receptors 1-4 
GTPase Guanosine-5'-triphosphatase 
HEK 293T human embryonic kidney 293T cells 
HSP70 heat shock protein 70 
IL-1β interleukin 1β 
IL-6 interleukin 6 
KA kainic acid (kainate) 
KO knockout 
MF methoxyflurane 
MK-801 [5R,10S]-[+]-5-methyl-10,11- dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine 
MP methylprednisolone 
NADH nicotinamide adenine dinucleotide 
NGF nerve growth factor 
NLS nuclear localization signal 
NMDA N-methyl-D-aspartate 
NO nitric oxide 
NT-3 and NT-4 neurotrophin 3 and 4 
NT-3 Neurotrophin-3 
PAR poly-ADP-ribose 
PARP1 poly-ADP-ribose polymerase-1 
PHE 6-5(H)-phenanthiridinone 
PJ34 N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-(N,N-dimethylamino) acetamide 
hydrochloride 
PTPC permeability transition pore complex 
RG rhythm generator 
Rho ρ factor 
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RIP1 receptor-activating protein 1 
RIP3 receptor-activating protein 3 
Ro15-4513 Ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo-1,4-benzodiazepine-3-
carboxylate 
ROI region of interest 
ROS reactive oxygen species 
TNFR1 tumor necrosis factor receptor-1 
TNFα tumor necrosis factor α 
VER155008 5'-O-[(4-cyanophenyl)methyl]-8-[[(3,4-dichlorophenyl) methyl]amino]-
adenosine 
VR ventral root 
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